Effect of yoghurt processing on beta-casomorphin 5 and beta-casomorphin 7 concentrations using novel liquid chromatography-mass spectrometry methods by Nguyen, Duc Doan
 
 
School of Public Health 
Nutrition, Dietetics and Food Science 
 
 
 
 
 
 
 
 
 
 
Effect of yoghurt processing on beta-casomorphin 5 and beta-
casomorphin 7 concentrations using novel liquid chromatography-
mass spectrometry methods 
 
 
 
 
 
 
 
 
 
Nguyen Duc Doan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This thesis is presented for the Degree of 
Doctor Philosophy 
of 
Curtin University 
 
 
 
 
 
 
 
 
June 2015
DECLARATION 
 
 
To the best of my knowledge and belief this thesis contains no material previously 
published by any other person except where due acknowledgment has been made. 
 
This thesis contains no material which has been accepted for the award of any other 
degree or diploma in any university. 
 
 
 
 
 
Signature:  
 
Date: 29/06/2015 
 
 
 
 
 
 
 
 
 
 
 
 
i 
 
  
 
 
 
 
 
 
 
 
 
I dedicate this PhD to my father Duan and stepmother Nhung, my wife Trang and my 
daughters An and My. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
ACKNOWLEDGEMENT 
I am sincerely grateful to my supervisor, Associate Professor Vicky Solah for her 
guidance to me to conduct this research. She also provided valuable suggestions and 
financial support throughout the course of my study.  
I am particularly grateful to my co-supervisor, Dr. Stuart Johnson and Dr. Francesco 
Busetti (Curtin Water Quality Research Centre) for their valuable suggestions as 
reviewing the manuscripts and the draft of the thesis. A special thank Dr. Francesco 
Busetti for his assistance throughout method development and analysis. 
I wish to thank Ministry of Education and Training, Vietnam and Curtin University 
for providing the funding to conduct this research. I appreciate all officers who work 
at Vietnam International Development (Ministry of Education and Training, 
Vietnam) and the Curtin Graduate Research School, International Office and School 
of Public Health for their help before and during my study. 
I would like to thank Dr. Tony James for his chairing and valuable suggestions when 
I was preparing the candidacy.  
I would like to thank all laboratory technicians for their technical help.  
I would like to thank Associate Professor Hannah Williams, who unfortunately had 
liver cancer and passed away, for her guidance during my candidacy. 
I thank Professor Jeffery Spickett and Dr. Evadne Spickett for kindly providing a 
home for my family. 
I appreciate Dr. Andrew Clarke, A2 Corporation Ltd., Australia for kindly providing 
UHT milk and skim milk powder. 
I wish to thank my colleagues (Faculty of Food Science and Technology, Vietnam 
National University of Agriculture) for their help during my leave. 
I would like to express my profound gratitude to my wife Trang, my daughters An 
and My, my parents and my sisters for their support during the long period of living 
in Australia. 
iii 
 
ABSTRACT 
The main objectives of this research project were to measure the concentration of 
beta-casomorphin 5 (BCM5) and beta-casomorphin 7 (BCM7) in milk and yoghurt 
and determine the effect of yoghurt processing on their concentration using novel 
liquid chromatography-mass spectrometry (LC-MS) methods. The thesis consists of 
three main parts: 1) Development of novel liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) and liquid chromatography-high resolution mass 
spectrometry (LC-HRMS) methods for simultaneous identification and quantification 
of BCM5 and BCM7; 2) Measurement of BCM5 and BCM7 in commercial dairy 
products; and 3) Effect of yoghurt processing on BCM5 and BCM7 concentrations. 
In this research project, commercial sandwich ELISA was also used for 
determination of BCM7 during yoghurt processing.  
The initial study was to develop a LC-MS/MS method for identification and 
quantitation of BCM5 and BCM7 in yoghurt and milk. Stable isotopes labelled 
BCM5-d10 and BCM7-d10 were used as internal standards. Samples were centrifuged 
and cleaned-up by 0.45 µm membranes and then dried until 1 mL under nitrogen 
flow, before LC-MS/MS analysis. Linearity (R2) observed in the range 0.01–10 
ng/µL were 0.9985 and 0.9986 for BCM5 and BCM7, respectively. Limits of 
detection (LODs) were found to be 0.5 ng/g for BCM5 and 0.25 ng/g for BCM7. 
LODs improvement was achieved during sample preparation by centrifuging and 
cleaning-up supernatants using solid phase extraction (SPE) instead of filtering 
through 0.45 µm membranes and subsequently drying extracts until 0.5 mL under 
nitrogen flow. The concentrated extracts were injected to LC-MS/MS and LC-
HRMS. LODs of LC-MS/MS method were 0.4 ng/g and 0.2 ng/g, while LODs of 
LC-HRMS were 0.25 ng/g and 0.1 ng/g for BCM5 and BCM7, respectively.  
Measurement of BCM5 and BCM7 content in 14 samples of Australian pasteurised 
milk, one sample of skim milk powder and ten samples of yoghurt were performed 
using novel LC-MS/MS and LC-HRMS methods. Neither BCM5 nor BCM7 were 
found in Australian commercial yoghurts. BCM5 was also below limit of detection 
(LOD) in all samples of pasteurised milk and skim milk powder. BCM7 was found 
between 0.13 and 2.38 ng/g in ten samples of pasteurised milk and skim milk 
powder. However, BCM7 content in four other samples of pasteurised milk was 
below LOD.  
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Effect of fermentation and storage on the degradation of BCM5 and BCM7 was 
conducted by measuring the variation in BCM5 and BCM7 concentrations during 
these processes. Yoghurt was produced by fermentation of reconstituted milk with a 
mixture of L. delbrueckii ssp. bulgaricus and S. thermophilus to pH 4.8 and 4.5 and 
then stored for one and seven days. BCM5 was below LOD at any fermentation pH 
and after any period of storage. BCM7 content decreased from 1.4 ng/g to 0.29 ng/g 
when reconstituted milk was fermented from pH 6.5 to pH 4.8, and completely 
degraded as prolonged fermentation to pH 4.5. BCM7 content in yoghurt produced 
by milk fermentation with these yoghurt cultures to pH 4.8 decreased from 0.29 ng/g 
to 0.17 ng/g after one day of storage and completely degraded after seven days of 
storage. Yoghurt produced by fermentation of milk to pH 4.5 contained BCM7 
below LOD after any time of storage.  
In addition, effect of yoghurt cultures on the degradation of BCM5 and BCM7 was 
also conducted in this research project. Synthesised BCM5 and BCM7 were spiked 
(40 ng/g) into ultra-high temperature (UHT) milk to investigate the remaining of 
these BCMs in yoghurt. Yoghurt was produced by inoculation of UHT with L. 
delbrueckii ssp. bulgaricus alone, S. thermophilus alone or a mixture of L. 
delbrueckii ssp. bulgaricus and S. thermophilus, and fermented to pH 4.5, which is a 
characteristic of final yoghurt, and then stored for one and seven days. Both BCMs 
were completely degraded in milk fermented to pH 4.5 and below LOD in yoghurt 
after any time of storage. The degradation of BCM5 and BCM7 in yoghurt 
processing is likely to be a result of X-prolyl dipeptidyl aminopeptidase (PepX) 
activity, which was produced by both L. delbrueckii ssp. bulgaricus and S. 
thermophilus. However, the degradation of BCM7 is due to the presence of yoghurt 
cultures, while the stability of BCM5 is affected by yoghurt cultures and pH. 
The applicability of a sandwich enzyme-linked immunesorbent assay (ELISA) test 
for quantitation of BCM7 in yoghurt was validated using the LC-MS/MS method. A 
sandwich ELISA test and LC/MS/MS were used to determine the BCM7 content in 
the samples mentioned. Two methods showed two different results of BCM7 content. 
Using LC-MS/MS, BCM7 content was found to be 1.4 ng/g, while it was 3.37×10-3 
ng/g using a sandwich ELISA test. LC-MS/MS showed that BCM7 content 
decreased during fermentation from 1.4 ng/g in reconstituted milk to 0.29 ng/g and 
below LOD in milk fermented to pH 4.8 and pH 4.5, respectively. BCM7 content in 
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yoghurt produced by fermentation of milk to pH 4.8 decreased to 0.17 ng/g after one 
day of storage and to below LOD after seven days of storage.  In contrast, ELISA 
data showed that BCM7 content increased during fermentation from 3.37×10-3 ng/g 
in reconstituted milk to 3.52×10-3 ng/g and to 12.22×10-3 ng/g in milk fermented to 
pH 4.8 and then pH 4.5, respectively. In yoghurt fermented to pH 4.8, BCM7 content 
increased to 3.99×10-3 ng/g and 12.78×10-3 ng/g after one and seven days of storage. 
After one day of storage, BCM7 in yoghurt fermented to pH 4.5 decreased very 
slightly to 12.19×10-3 ng/g; however, its content dramatically decreased to 2.19×10-3 
ng/g after seven days of storage. The results suggest that commercial sandwich 
ELISA test should not be used for quantitation of BCM7 in yoghurt and milk.   
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 Chapter 1 
CHAPTER 1 INTRODUCTION 
Milk as a nutritional food is well known as an important source of high-quality 
proteins and fat, due to its essential amino acids and unsaturated fatty acids. In 
addition, milk also contains a number of minor constituents including enzymes, 
vitamins, minerals, flavour compounds and bioactive peptides. All of these 
constituents make important contributions to the nutritional and technological 
properties of milk and dairy products (Fox & McSweeney, 1998). The current 
demand for milk and dairy products is not only due to their valuable nutrients, but 
also their role in prevention of chronic health conditions including obesity, dental 
decay, osteoporosis and hypertension (Nagpal et al., 2011). According to the Food 
and Agriculture Organisation of the United Nations (FAO), global consumption of 
milk has increased since early 1960s, and doubled in developing countries in recent 
years. Nations where per capita consumption of milk is high (> 150kg/capita/year) 
include Australia, Argentina, Europe, Israel, North America and Pakistan, whereas 
Senegal, most of Central Africa, Vietnam and Southeast Asia are low milk 
consuming countries (<30kg/capita/year).  In parallel, world milk production has 
risen by more than 50% in the last 30 years, between 1982 and 2012, and stood at 
approximately 750 million tonnes in 2012. India is the largest milk producing 
country with 16% of global production, followed by the United States of America, 
Brazil and China. A group of countries with the highest milk surplus are New 
Zealand, the United States of America, Germany, France and Australia 
Cow milk contains approximately 80% of casein, consisting of alpha s1-, alpha s2-, 
beta- and kappa-casein (αs1-CN, αs2-CN, β-CN and κ-CN, respectively). Beta-casein 
consists of 13 variants (see detail in Chapter 2), among which β-CN A1 and A2 
variants are predominant in milk. Milk containing both variants in equal amount is 
known as normal milk. However, milk can contain either β-CN A1 or A2 only, and 
these are called A1 milk or A2 milk, respectively. In recent years, Australian 
consumers and media have been concerned about several milk products described to 
contain more β-CN A2 variant than β-CN A1 variant. This concern has been 
triggered by epidemiological evidence that intake of milk containing more β-CN A1 
variant in nations with high consumption of milk is associated with non-
communicable diseases such as type 1 diabetes, heart diseases and schizophrenia 
(Birgisdottir, Hill, Thorsson, & Thorsdottir, 2006; Elliott, Harris, Hill, Bibby, & 
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Wasmuth, 1999; McLachlan, 2001). Potential factors derived from milk that may 
contribute to these disorders are the casein derived peptides, beta-casomorphins 
(BCMs). 
BCMs are a group of opioid peptides with morphin-like properties. These peptides 
contain a sequence of 4-11 amino acids and the same amino acid sequence at the  
first three residues. BCMs can be released from their parent β-CN at the amino acid 
residues 60-70 by enzymatic action. Among these, the β-CN fragment 60-64 (β-CN 
f60-64) and β-CN fragment 60-66 (β-CN f60-66) are named BCM5 and BCM7 (Fig. 
1), respectively and are two peptides with the most potent opioid properties. 
Epidemiological studies show that BCM7 is a risk factor contributing to type 1 
diabetes, heart disease, autism and schizophrenia, and BCM5 is associated with 
apnoea in infants (Elliott et al., 1999; McLachlan, 2001; Sun et al., 2003; 
Wasilewska, Maczmarski, Kostyra, & Iwan, 2011).  
 
Figure 1. Structure of BCM5 (A) and BCM7 (B) (Adapted from Juan-García, Font, 
Juan, & Picó, 2009) 
In dairy processing, bioactive peptides including BCMs are encrypted in an inactive 
form in parent caseins and can be released by bacteria-derived enzymes during 
fermentation of milk or storage of dairy products (Choi, Sabikhi, Hassan, & Anand, 
2012). In fermented milk, the amount and profile of bioactive peptides depends on 
the strains of microorganisms used for fermentation or the conditions and time of 
maturation and storage. Many cheeses have been reported to contain BCM5 and 
BCM7; while other cheeses contain neither BCM5 nor BCM7 (De Noni & Cattaneo, 
2010; Sienkiewicz-Szłapka et al., 2009). BCM7 is a factor causing bitter taste of 
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cheese (Shinoda, Tada, Okai, & Fukui, 1986). However, the presence of these 
peptides in pasteurised milk, UHT milk, milk powder and yoghurt are still equivocal.  
Yoghurt is a milk product widely used cross the world. It is made by fermentation of 
milk with two common lactic acid bacteria (LAB), L. delbrueckii ssp. bulgaricus and 
S. thermophilus and is defined as a lactic acid dairy product. In addition, yoghurt is 
also considered as a health beneficial food, rich in calcium, B group vitamins, 
essential fatty acids and bioactive peptides.  These peptides are mainly formed by 
LAB during fermentation or storage of the yoghurt. A large number of bioactive 
peptides have been reported as being generated in yoghurt manufacture, including 
antimutagenic, antimicrobial, anticarcinogenic, antioxidant, angiotensin I-converting 
enzyme  inhibitory (ACE-I) peptides as well as opioid peptides (Donkor, Henriksson, 
Singh, Vasiljevic, & Shah, 2007; Papadimitriou et al., 2007; Poyrazoglu Coban, 
Biyik, & Yavuz, 2012; Sabeena Farvin, Baron, Nielsen, Otte, & Jacobsen, 2010). 
However, some bioactive peptides, (for instance, those with antimicrobial and 
hypertensive activity) can be degraded by LAB during yoghurt fermentation or 
storage.     
The formation and/or degradation of BCM5 and BCM7 during manufacture of 
yoghurt has received a little attention in the scientific literature. There have been 
various studies attempting to measure these peptides in commercial yoghurt by 
different analytical methods. However, findings of the identification and 
quantification of BCM5 and BCM7 in yoghurt have provided contradictory results. 
This may be the result of differences in the source of milk, yoghurt starter cultures, 
storage conditions or sensitivity of the method used. 
In recent years, reversed-phase high performance liquid chromatography (RP-HPLC) 
and ELISA are methods of choice for detection and quantification of BCM5 and 
BCM7 (Muehlenkamp & Warthesen, 1996; Sienkiewicz-Szłapka et al., 2009). RP-
HPLC coupled to ultra violet-visible (UV-Vis) detection can be limited by 
interference of other peptides with similar physical-chemical properties, which can 
co-elute with target BCMs, increasing the absorption values and resulting in 
overestimated results. Furthermore, UV-Vis absorption may lack the sensitivity 
required to quantify BCM5 and BCM7 at low levels (Cass et al., 2008; 
Muehlenkamp & Warthesen, 1996). For ELISA, the quality of antibodies play 
important role for detection of target BCMs and it can influence the effectiveness of 
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analysis (Lutter, Parisod, & Weymuth, 2011). In addition, heat treatment of milk 
during yoghurt manufacture may modify the conformation of BCM7 by the 
interaction between lactose and amino acid residues, leading to a reduction in the 
binding affinity of the modified BCM7 to the antibody and resulting in 
underestimated results. 
Currently, liquid chromatography-mass spectrometry (LC-MS) is a powerful method 
for identification and quantification of peptides in complex matrices such as milk and 
yoghurt.  Different mass spectrometry techniques such as tandem mass spectrometry 
(MS/MS), quadrupole ion-trap mass spectrometry (QIT-MS) have been applied to 
determine BCM5 and BCM7 in yoghurt and milk (De Noni & Cattaneo, 2010; Juan-
García et al., 2009). The choice of the calibration technique plays a critical role in 
LC-MS quantitative analysis. External, internal, as well as matrix matched 
calibration standards can be used for this purpose. The effects of matrix components 
present in complex samples such as dairy products are known to be responsible for 
suppressing and, less frequently, for enhancing the absolute response of analytes. 
The use of external calibration standards is generally not recommended as it can 
result in erroneous quantitative results. The use of deuterated homologues is by far 
the most effective way of correcting matrix effects, as the analytes of interest and the 
deuterated homologues behave identically in the ionisation interface and therefore, 
are subjected to identical matrix effects. Alternatively, matrix matched calibration 
standards can be used to compensate fully for matrix effects. However, this approach 
is generally time consuming as it requires using the matrix (i.e. sample/ sample 
extract) to build the calibration curves (Jessome & Volmer, 2006).  
Therefore, the main objectives of this research are the: 
1. Development of LC-MS/MS using stable isotope-labelled compounds as internal 
standards for simultaneous quantification of BCM5 and BCM7 in milk and yoghurt. 
2. Identification and quantitation of BCM5 and BCM7 in pasteurised milk, skim milk 
powder and commercial yoghurt . 
3. Investigation of the formation and/or degradation of BCM5 and BCM7 during 
fermentation and storage of yoghurt. 
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4. Investigation of the effect of yoghurt cultures, L. delbrueckii ssp. bulgaricus and S. 
thermophilus used for fermentating individually on the formation and/or degradation 
of BCM5 and BCM7. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Bovine protein 
Milk is an important source of nutrients for not only newborn humans but also for 
adults. It contains minerals, vitamins, essential fatty acids and high quality proteins. 
The major milk proteins consist of caseins and whey proteins, amounting to 
approximately 80% and 20% of milk protein, respectively (Kopf-Bolanz et al., 
2012). Casein exists in milk in form of micelles (Fig. 2), consisting of four fractions: 
αs1, αs2, β and κ-CN. The αs1-, αs2- and β-CN are located in the core region of the 
micelle, whereas κ-CN is on micelle surface (Fig. 2) (Considine, Patel, Anema, 
Singh, & Creamer, 2007).  
 
Figure 2. Model of the casein micelle (Adapted from Gosta, 1995) 
β-CNs have a chain length of 209 amino acids (Fig. 3) and have  been found as 13 
variants in cow milk, namely β-CN A1, A2, A3, A4, B, C, D, E, F, H1, H2, I and H 
(Kamiński, Cieślińska, & Kostyra, 2007). Milk from most cows contains both β-CN 
A1 and β-CN A2 variants. Originally, when first domesticated, cows produce only 
pure β-CN A2 variant, however many herds in European countries produced mainly 
β-CN A1 variant (http://www.a2milk.co.uk).  Holstein-Friesian cows for instance, 
produce milk containing predominantly β-CN A1 variant (Tailford, Berry, Thomas, 
& Campbell, 2003), while Guernsey and Jersey breeds produce more β-CN A2 than 
β-CN A1 variant (Bell, Grochoski, & Clarke, 2006). The difference between β-CN 
A1 and A2 variant is only a single amino acid at position 67 at which the residue is 
histidine on β-CN A1 variant and proline on β-CN A2 variant (Fig. 3) 
(http://www.betacasein.org; Kamiński et al., 2007), leading to a difference in milk 
functionality between β-CN A1/A1 variant containing milk and β-CN A2/A2 variant 
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containing milk (Raynes, Day, Augustin, & Carver, 2015). More importantly, 
although both β-CN variants have sequence homology at residues 60-66, β-CN A1 
variant can be hydrolysed between residues 66-67 by proteases to give the opioid 
peptide known as BCM7, whereas β-CN A2 variant is resistant to enzymatic 
hydrolysis at these residues (Thiri et al., 2012; Jinsmaa & Yoshikawa, 1999).  
Epidemiological studies have reported that there are strong correlations between 
consumption of high β-CN A1 variant and type 1 diabetes and ischemic heart 
diseases (Elliott et al., 1999; McLachlan, 2001).  However, there is insufficient data 
for demonstration of the relationship between BCM7 and other related BCMs and 
non-communicable diseases (EFSA, 2009; Swinburn, 2004; Truswell, 2005).  
 
Figure 3. The primary structure of β-CN A2 variant indicating amino acid 
substitutions of the other variants (Adapted from Swaigood, 2003).  
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2.2 Source of beta-casomorphins 
Beta-casomorphins (BCMs) are a group of opioid peptides released from enzymatic 
hydrolysis of bovine β-CN (De Noni & Cattaneo, 2010) at amino acid positions 60-
70 (Boutrou et al., 2013). These peptides have a sequence of 4-11 amino acids 
(Kamiński et al., 2007) and the same sequence at the first three residues (-Tyr-Pro-
Phe-) (Muehlenkamp & Warthesen, 1996) (Table 1). Among these peptides, BCM5 
and BCM7 are peptides with the highest opioid activity (Brantl, Teschemacher, 
Bläsig, Henschen, & Lottspeich, 1981; Kálmán, Cserháti, Valkó, & Neubert, 1992) 
and have been studied more extensively than the other BCMs.  
BCM7 is cleaved from β-CN at amino acid positions 60-66 (Fig. 4) during in vitro 
enzymatic hydrolysis (Brantl, Teschemacher, Henschen, & Lottspeich, 1979; De 
Noni, 2008; Jinsmaa & Yoshikawa, 1999) and during in vivo human gastrointestinal 
digestion (Boutrou et al., 2013). BCM7 was hydrolysed only from β-CN A1 variant 
by pepsin in vitro (De Noni, 2008; Jinsmaa & Yoshikawa, 1999). Other BCMs such 
as BCM9 was generated from enzymatic hydrolysis of both β-CN A1 and β-CN A2 
variant in vitro (Jinsmaa & Yoshikawa, 1999). 
 
Figure 4. The release of BCM7 (Adapted from Woodford, 2009) 
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Table 1. Sequence of bovine BCMs  
Beta casomorphins Fragments Structure References 
Beta-casomorphin 4 (BCM4)  β-CNf(60-63) Tyr-Pro-Phe-Pro Kamiński et al. (2007), Matar and Goulet 
(1996), Brantl et al. (1981) 
Beta-casomorphin 5 (BCM5)  β-CNf(60-64) Tyr-Pro-Phe-Pro-Gly Kamiński et al. (2007), Juan-García et al. 
(2009), De Noni (2008), Brantl et al. (1981) 
Beta-casomorphin 6 (BCM6)  β-CNf(60-65) Tyr-Pro-Phe-Pro-Gly-Pro Kamiński et al. (2007)  
Beta-casomorphin 7 (BCM7)  β-CNf(60-66) Tyr-Pro-Phe-Pro-Gly-Pro-Ile De Noni (2008), Kamiński et al. (2007) 
Juan-García et al. (2009), Jinsmaa and 
Yoshikawa (1999), Brantl et al. (1981)  
Beta-casomorphin 8 (BCM8)  β-CNf(60-67) Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro Kamiński et al. (2007) 
Beta-casomorphin 9 (BCM9)  β-CNf(60-68) Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-
Asn 
Saito, Nakamura, Kitazawa, Kawai, and Itoh 
(2000), Jinsmaa and Yoshikawa (1999)  
Beta-casomorphin 10 (BCM10)  β-CNf(60-69) Tyr-Pro-Phe-Pro-Gly-Pro-Ile-His-
Asn-Ser 
Toelstede and Hofmann (2008) 
Beta-casomorphin 11 (BCM11)  β-CNf(60-70) Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-
Asn-Ser-Leu 
Kamiński et al. (2007) 
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2.3 Beta-casomorphins in dairy products 
2.3.1 Raw and heat-treated milk 
Bovine milk is not only a source of essential fatty acids, calcium and phosphate, and 
vitamins, but also provides high quality of protein that can generate bioactive 
peptides. These peptides are in an inactive form in the parent proteins and are 
released during fermentation of milk or during gastric digestion. Milk peptides with 
health beneficial effects may play an important role in prevention of hypertension 
(Jauhiainen & Korpela, 2007) and cardiovascular disease (Elwood, 2005). However, 
several bioactive peptides with opioid property released from bovine β-CN may 
increase risk of chronic disease (Cieślińska, Kaminski, Kostyyra, & Sienkiewicz-
Szłapka, 2007; Cieślińska et al., 2012). 
Bovine milk often contains somatic cells, native milk enzymes or bacteria 
contaminated from external environment. These are three factors that can contribute 
to the hydrolysis of proteins to peptides. Somatic cell count (SSC) in milk is an 
important factor for assessment of the severity of mastitis which indicates the 
inflammation of cow udders. Milk is considered as coming from a mastitis infected 
cow if somatic cells exceed 500,000 per millilitre (Ginn, Packard, Mochrie, Kelley, 
& Schultz, 1985). Many studies have measured BCM7 in milk collected from cows 
with different severities of mastitis. This peptide was found in fresh cow milk, in 
which somatic cells were not characterised (Cieślińska et al., 2007). Simlarly, 
Cieślińska et al. (2012) detected BCM7 in cow milk collected from healthy cows that 
did not indicate any sub-clinical symptoms of mastitis. In contrast, Napoli et al. 
(2007) have reported that BCM7 was undetectable at any level in milk collected from 
cows with mastitis. Consequently, somatic cells are not a factor associating with the 
presence of BCM7 in fresh milk.   
Endogenous proteases often present in milk during lactation consist of plasmin, 
cathepsins and elastase. According to Weinstein and Doolittle (1972), plasmin 
specifically cleaves the peptide bonds between lysine and arginine residue. As shown 
in Fig. 3, there is no lysine or arginine amino acid residue at positions from 59-70 on 
β-CN chain. In addition, plasmin hydrolyses peptide bonds on β-CN at amino acid 
residues Lys28 and Lys29, Lys105 and His106, and Lys107 and Glu108 (Fig.  3) (Aslam & 
Hurley, 1998). Meanwhile, cathepsins and elastase cleaved β-CNs to pro-beta 
casomorphins (pro-BCMs) such as β-CNf(54-68), β-CNf(55-68), β-CNf(57-68) and 
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β-CNf(55-65), but no BCMs (Gaucher, Mollé, Gagnaire, & Gaucheron, 2008).  More 
interestingly, cathepsin B cleaves β-CNs to BCM10 (β-CN f60-69) and an undefined 
peptide (β-CN f60-) (Considine, Healy, Kelly, & McSweeney, 2004). However, 
Meltretter, Schmidt, Humeny, Becker, and Pischetsrieder (2008) detected unknown 
peptides with mass-to-charge (m/z) from 1900 to 4500 in raw milk by matrix-assisted 
laser desorption/ionisation time of flight mass spectrometry (MALDI-TOF-MS). 
None of these m/z values matched those of BCMs suggesting the absence of BCMs 
in the raw milk. 
The contamination of bacteria from the external environment into milk always occurs 
during milking. Enzymes produced by these bacteria may hydrolyse β-CNs into 
BCM7 and other BCMs. Hamel, Kielwein, and Teschemacher (1985) have detected 
BCM7, BCM6, BCM5 and BCM4 immunoreactive material in fresh milk inoculated 
with bacteria frequently found in contaminated milk. 
Investigations of the occurrence of BCM7 and other BCMs in human milk may also 
assist in our understanding of the origin of formation of these peptides in bovine 
milk. Jarmołowska et al. (2007) have showed that BCM5 and BCM7 were detected 
in human milk that was collected from healthy women and stored at -70 °C 
immediately after expression. Obviously, in these conditions of collection and 
storage of milk samples, the hydrolysis of proteins by somatic cell or bacteria-
derived enzymes was very unlikely. Therefore, BCM5 and BCM7 were probably 
released from β-CNs in the mammary glands by endogenous proteinases before the 
milk was expressed (Koch et al., 1988). However, the identity of specific 
endogenous enzymes in human milk and their mechanism of action are unknown.  
The presence of β-CN variants and their ratio in milk plays an important role in the 
formation of BCM7 and other BCMs. As previously described, in vitro studies 
demonstrated that BCM7 is only released from β-CN A1 variant, but other BCMs can 
be released from both β-CN A1 and β-CN A2 variant (Jinsmaa & Yoshikawa, 1999). 
Surprisingly however, BCM7 has been found in milk containing not only the pure β-
CN A1 variant, but also β-CN A2 and β-CN A1/A2 (Cieślińska et al., 2012). The 
level of BCM7 is the highest in milk containing only β-CN A1 variant, followed by 
in milk containing β-CN A1/A2 variant and then β-CN A2 variant.  In this regard, 
BCM7 may be formed from β-CN A2 variant at very low rate (Korhonen & Marnila, 
2013). In contrast, De Noni and Cattaneo (2010) did detect neither BCM5 nor BCM7 
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in unprocessed milk, although this milk contains both β-CN A1 and β-CN A2 
variant. 
Heat-treated liquid milk is a product wildly consumed across the world.  It consists 
of pasteurised milk (75 °C/15s), UHT milk (UHT-149 °C/2s) and sterilised milk (110 
°C/10min). In addition to destroying bacteria, heat treatment of milk also changes its 
physio-chemical properties; for instance, increasing viscosity, browning of colour, 
changes in protein conformation and release of peptides. BCM7 has been found in 
commercial UHT milk (Juan-García et al., 2009; Thiri, Ardeshir, Andrew, and 
Xiaomin, 2012) and in pasteurised and sterilised milk (Cieślińska et al., 2012) (Table 
2). In contrast, De Noni and Cattaneo (2010) did not identify BCM5 and BCM7 in 
similar milk products. Another study showed five new peptides identified in cow 
milk that was heated at 72, 85 and 120 °C for 10, 20 and 30 min respectively, but 
neither contained  BCM7 nor other BCMs (Meltretter et al., 2008). These BCMs 
were also not identified in commercial UHT and pasteurised milk (Gaucher et al., 
2008; Meltretter et al., 2008).  
Overall, while some peptides in milk and heated milk released from β-CNs by 
endogenous proteases or heat treatment have been known, the presence of BCM5 and 
BCM7 in these milk products has been contradicted. This may be due to analytical 
methods used for identification and quantification of BCM5 and BCM7 (see detail in 
Section 2.6 and Chapter 4) or different origins of raw milk and heated milk used for 
measurement of these BCMs.    
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Table 2. BCMs in milk and milk products 
Milk and milk products Beta-casomorphins Levels References 
Milk     
  Fresh milk 
BCM7 
Identified Cieślińska et al.(2007) 
 1.1-2.1a Cieślińska et al. (2012) 
  Pasteurised milk 3.3-6.1a Cieślińska et al. (2012) 
  UHT milk 1.4a Juan-García et al. (2009) 
  0.2a Thiri et al. (2012) 
  Sterilised milk 2.9-7.4a Cieślińska et al. (2012) 
Cheese    
 Brie 
BCM7 
5 – 15b  Jarmolowska et al. (1999) 
  0.15b De Noni and Cattaneo (2010) 
   6.48b Sienkiewicz-Szłapka et al. (2009) 
 BCM5 3.14b  Sienkiewicz-Szłapka et al. (2009) 
 Cheddar 
BCM7 0.11-1.0b 
De Noni and Cattaneo (2010); Norris, Coker, 
Boland, and Hill (2003) 
 BCM6 Identified Norris et al. (2003) 
 BCM9 Identified Singh et al. (1997) 
 EMC BCM7 Identified Haileselassie, Lee, and Gibbs (1999) 
 Gorgonzola BCM7 0.01b  De Noni and Cattaneo (2010) 
 Fontina BCM7 0.04b De Noni and Cattaneo (2010) 
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 Gouda 
BCM7 
0.06b  Sienkiewicz-Szłapka et al. (2009) 
 0.1b  De Noni and Cattaneo (2010) 
 0.066b Norris et al. (2003) 
 BCM5 0.05b Sienkiewicz-Szłapka et al. (2009) 
 BCM9 identified Saito et al.(2000), Toelstede and Hofmann (2008) 
 BCM10 identified Toelstede and Hofmann (2008) 
 Rokpol BCM7 1.66b Sienkiewicz-Szłapka et al. (2009) 
 BCM5 2.57b Sienkiewicz-Szłapka et al. (2009) 
 Edamski BCM7 1b Sienkiewicz-Szłapka et al. (2009) 
 BCM5 0.46b Sienkiewicz-Szłapka et al. (2009) 
 Kasztelan BCM7 0.04b Sienkiewicz-Szłapka et al. (2009) 
 BCM5 0.14b Sienkiewicz-Szłapka et al. (2009) 
 Swiss BCM7 0.22b Norris et al. (2003) 
 BCM6 identified Norris et al. (2003) 
 Elsberg BCM7 0.11b Norris et al. (2003) 
 BCM6 identified Norris et al. (2003) 
 Feta BCM7 0.15b Norris et al. (2003) 
 BCM6 identified Norris et al. (2003) 
 Blue BCM7 23.2b Norris et al. (2003) 
 BCM6 identified Norris et al. (2003) 
Milk powder and formula    
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 Milk powder BCM7 0.8-2.7c Cieślińska et al. (2012) 
 Infant formula BCM5 0.39d Jarmołowska et al.(2007) 
 High protein formula BCM5 0.004b Wocior (2008) 
Yoghurt     
 Probiotic yoghurt BCM7 46e Jarmolowska (2012) 
 Traditional yoghurt BCM7 54e Jarmolowska (2012) 
 Kefir BCM7 29e Jarmolowska (2012) 
a ng/mL of milk  
b ng/mg of cheese or high protein formula 
c ng/mL of reconstituted milk  
d ng/µL of reconstituted infant formula 
e ng/mg of protein in yoghurt 
ECM – enzyme modified cheese (Cheddar) treated with Neutrase protease produced from Bacillus subtilis  
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2.3.2 Cheese 
Cheese is a dairy product produced by coagulation of casein protein in cow, buffalo, 
ewe or goat milk. During cheese production, milk is heated, acidified by inoculation 
with stater culture and the addition of the enzyme rennet to coagulate caseins to give 
curd and whey. Further processes are: to separate the whey, press the curd into a 
mount and ripening of the curd into the final cheese. Moreover, for many varieties of 
cheese, specific moulds are also added during ripening. 
Milk used for cheese making is commonly pasteurised at 72 °C for 15s (Hayaloglu, 
Deegan, & McSweeney, 2010). However, some varieties of cheeses are produced 
from milk without heat treatment or alternately milk heated at higher temperature 
than pasteurisation (>72 °C). Heat treatment of milk causes denaturation of the whey 
proteins, beta-lactoglobulin (β-LG) and alpha-lactalbumin (α-LA), leading to 
interaction between caseins and denatured whey proteins (Fig. 5). This interaction 
not only leads to increase in the yield of cheese, but also significantly affects 
hydrolysis of proteins during ripening, impacting the flavour and texture of final 
products (Benfeldt & Sørensen, 2001). In addition, using different starter cultures for 
fermentation or moulds for ripening also contributes to variations in the peptide 
profile in the ripened cheese. In general, protease systems cleave proteins into a 
number of larger peptides during ripening, which are subsequently further 
hydrolysed into smaller peptides (Benfeldt & Sørensen, 2001). The peptide, β-
CNf58-72 called pro-beta casomorphin (pro-BCM), was found in Crescenza cheese 
after 8-10 day ripening (Smacchi & Gobbetti, 1998) and in Cheddar and Jarlsberg 
cheese (Stepaniak, Fox, Sorhaug, & Grabska, 1995). This peptide may be cleaved by 
peptidases into beta-casomorphin 13 (BCM13, β-CNf60-72) as reported by Jinsmaa 
and Yoshikawa (1999),  or into other smaller BCMs if the cheese is ripened for a 
longer period.  
In recent years, the presence of BCMs in cheese, especially BCM5 and BCM7, has 
been investigated (De Noni & Cattaneo, 2010; Sienkiewicz-Szłapka et al., 2009). 
The levels of BCMs in some cheeses are showed in Table 2.  BCM7 has been found 
in varieties such as Brie, Cheddar, Gorgonzola, Fontina, Gouda, Rokpol, Edamski, 
Kasztelan, Swiss, Elsberg, Feta and Blue (De Noni & Cattaneo, 2010; Norris et al., 
2003; Sienkiewicz-Szłapka et al., 2009). Some cheeses have also been reported to 
contain BCM5, for example Brie, Rokpol, Edamski, Gouda and Kasztelan 
16 
 
 Chapter 2 
(Sienkiewicz-Szłapka et al., 2009), BCM6 in Blue, Cheddar, Feta, Swiss, Gouda and 
Elsberg (Norris et al., 2003). BCM9 has been reported in Cheddar and Gouda (Saito 
et al., 2000; Singh et al., 1997; Toelstede & Hofmann, 2008), BCM10 in Gouda 
(Toelstede & Hofmann, 2008), and BCM11 in the Italian goat cheese Caprino del 
Piemonte (Rizzello et al., 2005).  In contrast, other studies did not detect BCM7 or 
other BCMs in Brie and Cheddar (Alli, Okoniewska, Gibbs, & Konishi, 1998; 
Muehlenkamp & Warthesen, 1996). These findings may indicate that BCM7 is (a) 
not probably formed from β-CNs, (b) may be degraded during cheese ripening or (c) 
present at a level lower than LOD of the analytical method used. 
SCC in raw milk is one of important factors for assessment of the suitability of milk 
for production of cheese (Siobhan, Denise, Patrick, & Alan, 2000). Increasing SCC 
in milk is significantly associated with higher endogenous protease activity, from 
enzymes such as cathepsin B and D and elastase. This enzymatic activity plays a 
major role in the hydrolysis of caseins, with potential for reducing yields due to loss 
of proteose-peptones in whey (Albenzio et al., 2009). Endogenous proteases 
significantly contribute to peptide profiles in cheese during ripening, however; 
neither BCM nor other BCMs were identified (Gagnaire et al., 2011).  
Plasmin is a main endogenous protease originating from the cow’s blood (Considine, 
Healy, Kelly, & McSweeney, 1999) and its activity is therefore, not associated with 
SCC (Siobhan et al., 2000). Furthermore, its activity is unaffected by pasteurisation 
of milk at 72 °C/60 s or at 80 °C/15s (Benfeldt, Sørensen, Ellegård, & Petersen, 
1997). This enzyme has been thought to play a role in aging of Cheddar, Swiss-type 
cheese and Gouda (Farkye & Fox, 1992; McSweeney, Pochet, Fox, & Healy, 1994). 
Some peptides released from β-CNs by plasmin have been isolated from Cheddar 
cheese, but no BCM7 or other BCMs were reported (Farkye & Fox, 1992; 
McSweeney et al., 1994). According to McSweeney (2004), rennet enzymes 
(chymosin) also cleaved β-CNs in a similar manner to plasmin, elastase and 
cathepsin. Therefore, any single endogenous protease or chymosin is incapable of 
releasing BCM7 or other BCMs during cheese ripening. However, a combination of 
these enzymes and others derived from LAB or mould may play a role in formation 
of BCMs and the BCM-releasing activities, however, this needs further investigation.    
LAB is often used as a starter culture for fermentation of milk during cheese making. 
In addition to producing lactic acid to coagulate milk protein, LAB also hydrolyses 
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milk proteins into peptides, including BCM7 and other BCMs, during fermentation 
and cheese ripening. The formation or degradation of BCM7 and other BCMs may 
depend on the strains of LAB culture and cheese making conditions. The BCM7 and 
other related BCMs in cheese could not originate from the milk, because if so, these 
peptides would be removed in the whey fraction during washing of the curd 
(Jarmolowska et al., 1999). De Noni and Cattaneo (2010) found BCM7 at 0.11 
ng/mg in Cheddar cheese. In the manufacture of Cheddar, starter cultures that are 
commonly used for fermentation include a mixture of Lactococcus lactis ssp. 
cremoris and Lactococcus lactis ssp. lactis (Robinson, 1995). Muehlenkamp and 
Warthesen (1996) showed that BCM7 level decreased by 50% after 6-15 weeks of 
storage when it was incubated with Lactococcus lactis ssp. cremoris at pH 5.0 and 
1.5% NaCl. These conditions of incubation and storage are similar to those used in 
production of Cheddar cheese. According to Haileselassie et al. (1999), BCM7 was 
detected in emulsified Cheddar cheese with added Neutrase, an enzyme produced 
from Bacillus subtilis, after an eight hour incubation. However, the produced BCM7 
was degraded by peptidases from L. casei,  Lactococcus lactis and Aspergillus 
oryzae after a 72 hour incubation. Therefore, BCM7 may be generated from 
hydrolysis of β-CNs during fermentation, followed by degradation into smaller 
peptides by LAB in ripening. 
Non-starter microflora plays a role similar to starter cultures in cheese making.  Non-
starter microflora is microflora that has contaminated the raw milk from cow udders, 
equipment and pipes during milking and transportation.  In addition to lactic acid 
fermentation, these microorganisms hydrolyse caseins into peptides, and further into 
amino acids, leading to production of unique desired flavours of these cheeses. 
Therefore, many types of cheese are made from milk without heat treatment in order 
to benefit from the flavour profiles generated by these non-starter microorganisms. In 
addition, in cheese making, pasteurisation of milk does not kill all non-stater 
microflora, therefore, those that do survive can still hydrolyse milk proteins into 
peptides during fermentation or ripening.  Hayaloglu et al. (2010) showed that 
content of peptides in Malatya cheese made from raw milk without addition of starter 
culture is higher than that in cheese made from pasteurised milk inoculated with 
Lactococcus lactis ssp. lactis and S. thermophilus. The authors suggested that the 
resultant peptides were generated from activity of non-starter culture derived 
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enzymes, not from those derived from Lactococcus lactis ssp. lactis and S. 
thermophilus starter culture. However, BCM7 and other BCMs in this cheese were 
not identified. 
In addition to starter culture, mould is also used for ripening in some cheeses such as 
Brie, Camembert or Gorgonzola. This microorganism strongly influences the 
appearance, flavour and texture of these cheeses (Wilhelm, 1999). According to 
Takafuji (1993), mould-derived proteases play a role in degradation of β-CNs into 
large peptides, once the level of activity the enzymes increased after 20 day ripening. 
Subsequently, large peptides were hydrolysed into smaller ones by LAB derived 
enzymes. However, the role of LAB or mould in formation of BCM5 and BCM7 in 
these cheeses remains poorly understood.  The level of BCM7 and BCM5 in Brie 
cheese and Rokpol cheese ripened with both mould and LAB was considerably 
higher than that in other cheeses ripened with only LAB (De Noni & Cattaneo, 2010; 
Sienkiewicz-Szłapka et al., 2009). Similarly, other authors have reported high levels 
of BCM7 in Brie (Jarmolowska et al., 1999) and in Blue cheese (Norris et al., 2003).   
As previoulsy described in Section 2.2, BCM7 is generated from digestion of β-CN 
A1 variant by gastric enzymes. However, the link between β-CN A1 or β-CN A2 
variants in the formation of BCM7 in milk products or in cheese currently has beeen 
received little attention. Almost all studies that have investigated BCM7 and other 
related BCMs in commercial cheeses did not characterise the type of β-CN variant of 
the raw milk or the resulting cheese. However, according to De Noni and Cattaneo 
(2010), both β-CN A1 and β-CN A2 variants were identified in cheeses where BCM7 
was detected.  Therefore, it will now be necessary to elucidate which variant is the 
source of BCM7 during cheese making by future investigations on the occurrence of 
BCM7 and other related BCMs in cheese produced from milk of a single β-CN 
variant.      
2.3.3 Milk powder and milk formulas 
Milk powder is a dairy product mainly produced from bovine milk by dehydration, 
so that the product contains 3-5% water. It is one of main ingredients to be blended 
into formulas. In general, the main process in the manufacture of milk powder is heat 
treatment (including pasteurisation), concentration under vacuum and spray drying. 
In recent years, several studies have reported the occurrence of BCM7 and other 
related BCMs in the milk powder. Cieślińska et al. (2012) indicated that the level of 
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BCM7 of milk reconstituted from powder containing β-CN A1 and β-CN A2 variants 
ranged between 0.8 and 2.7 ng/ml (Table 2). Wocior (2008) and Jarmołowska et al. 
(2007) found BCM5 in milk powder-based high protein formulas and infant 
formulas. In contrast, De Noni and Cattaneo (2010) in their study on products 
containing both β-CN A1 and β-CN A2 variants, detected neither BCM7 nor BCM5 
in commercial skim milk powder or in other products such as calcium caseinate, milk 
protein concentrate or milk-powder based infant formulas. Therefore, the presence of 
BCM7 and BCM5 milk powder and formulas involves pre-existence of these 
peptides in the raw milk before it was processed into milk powder. 
2.3.4 Yoghurt 
Yoghurt is a dairy product mainly produced from bovine milk by fermentation. 
Yoghurt fermented with LAB, L. delbrueckii ssp. bulgaricus and S. thermophilus 
(Tamime & Robinson, 1999) is known as traditional yoghurt.  In recent years, 
probiotic yoghurt also has been produced by incubation of milk with probiotic 
bacteria such as Bifidobacterium, L. acidophilus or L. casei. Yoghurt is regarded as a 
nutritious milk product with health beneficial properties since it is rich in calcium, B-
group vitamins, essential fatty acids and bioactive peptides. Peptides with bioactive 
properties such as ACE-I, antioxidant, antimicrobial or opioid peptides have been 
found in yoghurt (Donkor et al., 2007; Jarmolowska, 2012; Kunda et al., 2012; 
Papadimitriou et al., 2007; Poyrazoglu Coban et al., 2012; Sabeena Farvin et al., 
2010). 
Recently, BCM5 and BCM7 have been investigated in commercial yoghurt or 
fermented milk. According to De Noni and Cattaneo (2010), yoghurt and other 
fermented milk products contained neither BCM5 nor BCM7. In contrast, the later 
was found in traditional and probiotic yoghurt (Jarmolowska, 2012). A number of 
different peptides are also formed from β-CNs during traditional and probiotic 
yoghurt production (Donkor et al., 2007; Kunda et al., 2012; Schieber & Brückner, 
2000).  Various identified peptides are pro-BCMs, namely β-CNf57-68 and β-
CNf57-72 (Plaisancié et al., 2013; Schieber & Brückner, 2000); β-CNf58-72, β-
CNf59-68, β-CNf59-70 (Kunda et al., 2012), and β-CNf59-72 (Plaisancié et al., 
2013). In principle, these pro-BCMs may be further degraded by peptidase system of 
yoghurt starter cultures into BCMs during storage. To date, the peptide, β-CNf60-72 
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called BCM13 (Kunda et al., 2012) and BCM9 (Sabeena Farvin et al., 2010) have 
been found in commercial yoghurt.  
According to Kunda et al. (2012), two di-peptides, probably β-CNf60-61 and β-
CNf62-63, cleaved from both β-CN A1 and β-CN A2 variants were identified in 
commercial yoghurt. As illustrated in Fig. 3, residues at position 61 and 63 on the 
chain of parent β-CNs are proline residues. The peptide bonds between proline and 
other amino acids are hydrolysed by the enzyme PepX that is released from LAB 
(Gobbetti, Stepaniak, De Angelis, Corsetti, & Di Cagno, 2002). Therefore, the 
finding of Kunda et al. (2012) indicates that BCM7 and other BCMs are likely to be 
digested into smaller peptide fragments during yoghurt fermentation or storage. 
However, Kunda et al. (2012) did not isolate and characterise bacteria, a key factor 
influencing generation and degradation of the BCMs, present in the investigated 
yoghurt. 
L. delbrueckii ssp. bulgaricus and S. thermophilus grow symbiotically (proto-
cooperation), during yoghurt fermentation. In this symbiosis, metabolites released by 
each organism stimulate the growth of the other (Tamime & Robinson, 1999). In 
summary, L. delbrueckii ssp. bulgaricus produces peptides or amino acids that 
stimulate the growth of S. thermophilus (Courtin, Monnet, & Rul, 2002). In turn, S. 
thermophilus releases pyruvic acid, formic acid, folic acid, fatty acids and CO2 that 
stimulate the growth of L. delbrueckii ssp. bulgaricus (Settachaimongkon et al., 
2014). However, the symbiosis between these two yoghurt bacteria is dependent on 
the strain of S. thermophilus used for co-fermentation (Settachaimongkon et al., 
2014). Therefore, in yoghurt fermentation there may formation of BCM7 and other 
BCMs by L. delbrueckii ssp. bulgaricus with their subsequent degradation by S. 
thermophilus, and vice versa. It is unknown if, and when BCMs are released or 
degraded in yoghurt processing as using starter cultures L. delbrueckii ssp. 
bulgaricus and S. thermophilus. Therefore, this interaction needs further 
investigation. 
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2.4 Effect of processing on formation and degradation of beta-casomorphins 
and other peptides  
2.4.1 Effect of heat treatment  
Thermal treatment plays an important role in dairy processing in terms of food safety 
and quality. In addition to killing unwanted bacteria, thermal treatment causes 
change in composition and properties of milk (Hattem, Manal, Hanaa, & Elham, 
2011), especially resulting in the denaturation of whey proteins. Heating of milk 
above 70 °C (the temperature above which most milk products are exposed to during 
manufacture), causes significant denaturation of two major whey proteins, β-LG and 
α-LA (Considine et al., 2007). The denatured whey proteins can interact with casein 
micelles, particularly the κ-CN on the micelle surface (Fig. 2). This forms a complex 
of κ-CN~β-LG (Fig.5), which affects the physical and chemical properties of milk 
products (Krasaekoopt, 2003). In addition, heat treatment can induce protein 
fragmentation to form lower molecular weight peptides (Gaucheron, Mollé, Briard, 
& Léonil, 1999). 
 
 
Figure 5. Formation of κ-CN~β-LG complex during heat treatment of milk (Adapted 
from Gosta, 1995) 
According to Meltretter et al. (2008), five new peptides were generated after heat 
treatment of milk.  Peptides of unknown structure with mass-to-charge (m/z) ratios of 
974.4, 2218.7, 3730.1, 4297.8 and 4436.8 were generated from caseins, none of 
which were reported as BCM7 nor other BCMs.  In contrast, in another study, the 
level of BCM7 was reported to significantly increase on heating milk (Cieślińska et 
al., 2012). Compared to the raw milk, after pasteurisation (90 °C/20 min) or 
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sterilisation (117 °C/ 5 min), the BCM7 content increased approximately 3 or 2 fold, 
respectively (Table 2) (Cieślińska et al., 2012). 
In principle, the formation of new peptides or BCM7 can be due to heat treatment, 
enzymes or acid hydrolysis. The hydrolysis of proteins by enzymes or acid during 
heat treatment of milk can be excluded because enzymes are inactivated and pH of 
heated milk changes a little compared to that of raw milk. However, thermal 
treatment results in a Maillard reaction that may form radicals attacking the peptide 
bonds to cleave the bonds releasing peptides (Meltretter et al., 2008).  
The strength of peptide bonds is an important factor for fragmentation of protein by 
heat treatment. Gaucheron et al. (1999) have reported that ten peptides were 
generated in raw skim milk heated at 120 °C for 30 min. Two of which were liberated 
from β-CNs, including β-CNf1-14 and β-CNf1-16, but neither BCMs nor pro-BCMs 
were found.  The peptides were liberated after heating due to cleavage at bonds 
containing aspartic acid (Asp), asparagine (Asn) or glutamic acid (Glu). The peptide 
bonds involving these amino acids are thus more susceptible to cleavage by heat 
treatment (Hustinx, Singh, & Fox, 1997). Gaucher et al. (2008) identified pro-BCMs 
in UHT milk, namely β-CNf54-68, β-CNf54-69, β-CNf55-65, β-CNf55-68 and β-
CNf57-68, and suggested that these peptides derived from elastase and cathepsin 
enzymatic hydrolysis.  Three peptides (β-CNf54-68, β-CNf55-68 and β-CNf57-68) 
resulted from cleavage of peptide bonds involving the Asn residue at position 68. 
Therefore, this finding may indicate that peptide bonds containing Asn are more 
susceptible to hydrolysis by enzymes if milk is heated. Several studies have showed 
that the peptides β-CNf57-68 and β-CNf59-68 both contain Asn residue at position 
68, are also found in yoghurt (Kunda et al., 2012; Plaisancié et al., 2013; Schieber & 
Brückner, 2000). The formation of these two peptides is due to the heat treatment of 
milk rather than at the later fermentation and storage stages. 
The pasteurisation of milk prior to manufacture of dairy products plays an important 
role in subsequent proteolysis during the fermentation and storage stages (El-Zahar, 
Chobert, Dalgalarrondo, Sitohy, & Haertle', 2004). Although heating is widely used 
for killing non-starter microflora in the milk used for cheese production, though as 
previously described, some cheeses are still made from raw milk because of their 
distinctive flavours (Atasoy, Yetişmeyen, Türkoğlu, & Özer, 2008). Hayaloglu et al. 
(2010) showed that pasteurisation of milk (72 °C/ 30 s) resulted in a decrease in 
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peptide content of the resulting cheese compared to that in cheese made from raw 
milk; however, the identity of the  peptides was not reported. According to 
Hayaloglu et al. (2010), heat treatment of milk at 72 °C/ 30 s can kill non-starter 
microflora that may result in less peptides in cheese made from pasteurised 
compared to raw milk. In contrast, Mendia et al. (2000) reported that pasteurisation 
resulted in increase in proteolysis of β-CNs in cheese. This phenomenon may be 
linked to heat-induced activation of plasmin, one of the native enzymes in milk is 
quite heat stable. According to  Benfeldt and Sørensen (2001) and Mendia et al. 
(2000), when milk is pasteurised, plasmin is not inactivated and β-CN protein is 
dissociated from the casein micelles (Considine et al., 2007), which allows plasmin 
or other still active proteases hydrolyse the β-CNs more easily.  
2.4.2 Effect of fermentation and storage  
Fermentation is an extremely important process in the production of milk products 
such as yoghurt and cheese. In addition to conversion of lactose into lactic acid and 
breakdown milk fat into fatty acids, bacteria also hydrolyse proteins into peptides 
and amino acids during fermentation (Smit, Smit, & Engels, 2005). The extent and 
kinetics of these reactions depends on the strains of bacteria used for fermentation, 
temperature and time of incubation, and period of storage. 
The choice of strains of culture plays a crucial role in determining the properties of 
fermented milk including the peptides profile in the final products (Jarmolowska, 
2012). Gobbetti et al. (2000) have identified some peptides, namely β-CNf6-14, βCN 
f7-14, β-CNf73-82, β-CNf74-82 and β-CNf75-82, in yoghurt inoculated with a single 
strain of L. delbruekii ssp. bulgaricus SS1.  Papadimitriou et al. (2007) have 
identified β-CNf176-180 and β-CNf1-8 in yoghurt fermented with only L. delbruekii 
ssp. bulgaricus ϒ 10.13.To date, many studies have reported the finding of BCM7 
and other BCMs in some types of cheese (Table 2), however, the bacteria strains 
responsible have not been characterised. Some types of bacterial strains that have 
been reported as possibly capable of releasing BCM7 and other BCMs in cheese or 
yoghurt are summarised in Table 3.     
L. delbrueckii ssp. bulgaricus and S. thermophilus are often used for co-fermentation 
in traditional yoghurt and have been characterised in commercial yoghurt (De Noni 
& Cattaneo, 2010; Jarmolowska, 2012; Schieber & Brückner, 2000). De Noni and 
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Cattaneo (2010) showed that yoghurt stored for 30 days at cold temperature before 
analysis did not contain BCM5 or BCM7. The same finding was reported by 
Schieber & Brückner (2000) investigating yoghurt stored for 21 days at 4 °C. Thus, 
these results suggest that the mixture of starter culture L. delbrueckii ssp. bulgaricus 
and S. thermophilus is not capable of forming BCMs, or they can generate BCMs 
which are subsequently degraded during storage.  This suggestion is also supported 
by the analysis of  a 35-day stored Taleggio cheese fermented using L. delbrueckii 
ssp. bulgaricus and S. thermophilus as the starter culture, in which no BCM7 nor 
BCM5 were detected (De Noni & Cattaneo, 2010). Donkor et al. (2007) have 
identified several peptides originated from β-CNs in probiotic yoghurt fermented 
with L. delbrueckii ssp. bulgaricus LB1466 and S. thermophilus St1342, and 
probiotic bacteria L. casei L26, L. acidophilus L10 and Bifidobacterium lactis B94, 
but the presence of neither BCM7 nor other BCMs has been reported. In contrast, 
Jarmolowska (2012) quantified BCM7 in commercial traditional and in probiotic 
yoghurt and showed that its level decreased during storage. 
As described previously, BCM7 is a peptide rich in proline (Fig. 4) and therefore is 
highly susceptible to LAB derived PepX that preferentially cleaves peptide bonds 
involving this amino acid. Atlan et al. (1990) demonstrated that PepX is located in 
the cytoplasm and thus is released into the surrounding medium when there is lysis 
of bacteria cells. In the low pH and cold conditions during yoghurt storage, bacterial 
cells become unstable and more susceptible to lysis to potentially release more PepX 
(Otte, Lenhard, Flambard, & Sørensen, 2011). As a result, the decrease in BCM7 
during storage demonstrated by Jarmolowska (2012) and the absence of BCM7 or 
BCM5 in yoghurt and cheese stored for 30 or 35 days reported by De Noni and 
Cattaneo (2010) may be associated with increase in PepX activity. On the other hand, 
during fermentation, proteases associated to the cell wall of bacteria can hydrolyse 
caseins into large peptides which subsequently are transported into the bacteria cell 
and hydrolysed into di and tri-peptides (Nielsen, Martinussen, Flambard, Sørensen, 
& Otte, 2009). Consequently, L. delbrueckii ssp. bulgaricus and S. thermophilus used 
as co-culture in yoghurt production may cleave β-CNs into BCM7 and other related 
BCMs during fermentation and subsequently degrade them into even smaller 
peptides during storage.    
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The pH at which the fermentation is halted is a key factor affecting subsequent 
proteolysis during cold storage of fermented milk. Fermentation process is often 
stopped at pH 3.5-4.6 prior to cold storage.  According to Nielsen et al. (2009), 
fermentation by Lactococcus lactis and L. helviticus strains to pH 4.6 or 4.3 resulted 
in release of large peptides from β-CNs after 7-day cold storage. However, there was 
no change in peptide profile during storage when milk had been fermented with S. 
thermophilus to these same pH values. Antimicrobial and hypotensive peptides are 
degraded very slightly after a four hour incubation with strains of S. thermophilus at 
pH 4.5 (Paul & Somkuti, 2009). Thus, these findings suggest that S. thermophilus 
derived proteases or peptidases may not be active during cold storage at these pH 
values.  
Unlike fermentation with S. thermophilus, fermentation with L. delbrueckii ssp. 
bulgaricus results in significant hydrolyses of antimicrobial and hypotensive peptides 
after a four hour incubation at pH 4.5 (Paul & Somkuti, 2009). This study indicated 
that any BCMs formed during yoghurt fermentation or pre-existing in the milk 
before yoghurt making may be degraded during storage at pH 4.5. Currently, there is 
very little research on the effect of final fermentation pH value on the changes in 
level (e.g., by release of degradation) of BCMs during cold storage of yoghurt 
fermented with L. delbrueckii ssp. bulgaricus and S. thermophilus.  
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Table 3. Presence of BCMs in milk products fermented with different bacteria 
Beta-casomorphins Milk products Starter culture Origin References 
BCM4 Fermented milk L. helveticus (mutant) Bovine  milk Matar and Goulet (1996) 
BCM5 Cheese 
Lactococcus lactis ssp. lactis and S. 
thermophilusa 
Bovine milk 
Sienkiewicz-Szłapka et al. 
(2009) 
BCM7 
Cheese 
S. salivarius ssp. thermophilus, 
Lactococcus lactis ssp. lactis and 
Lactococcus lactis ssp. cremorisb 
Bovine milk 
De Noni and Cattaneo 
(2010), Sienkiewicz-
Szłapka et al. (2009), 
Jarmolowska et al. (1999) 
Traditional yoghurt 
L. delbrueckii ssp. bulgaricus and S.  
thermophilus 
Bovine milk 
Jarmolowska (2012) 
Probiotic yoghurt 
L. delbrueckii ssp. bulgaricus, S.  
thermophilus and Bifidobacterium 
Bovine milk 
Jarmolowska (2012) 
BCM9 Cheese 
Lactococcus lactis spp. lactis  and 
Leuconostoc mesenteroides ssp. 
dextranicum 
Ovine milk 
Gómez-Ruiz, Ramos, and 
Recio (2004) 
 a stater culture used for Gouda cheese making (Messens, Estepar-Garcia, Dewettinck, & Huyghebaert, 1999) 
b stater culture used for Brie cheese making (Lefier, Lamprell, & Mazerolles., 2000) 
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2.4.3 Effect of cross-linking of protein 
It is well-known that heat treatment of milk forms a κ-CN~β-LG complex (Fig.5) 
resulting from di-sulphide linkage. There are many studies reporting the effect of 
heat treatment of milk on the interaction between κ-CN and β-LG and leading to 
changes in properties of milk products. For β-CNs alone, the formation of inter/intra-
molecular di-sulphide bonds by heat treatment of milk is very unlikely due to the 
lack of cysteine residues. However, the sequence of β-CNs contains four tyrosines, 
eleven lysines and twenty glutamines, so its higher level structure can be modified by 
formation of covalent cross-linking between tyrosine-tyrosine or lysine-glutamine by 
treatment of milk with the enzymes tyrosinase and transglutaminase (TGase), 
respectively (Monogioudi et al., 2009).  
TGase (EC.2.3.2.13) catalyses the formation of covalent cross-linking between lysine 
and glutamine (Domagała, Wszołek, Tamime, & Kupiec-Teahan, 2013), leading to 
modification of the water holding capacity, viscosity or foaming properties of food 
products. Recently, application of TGase to modify proteolysis and texture of 
yoghurt has been reported (Domagała et al., 2013; SanlI, Sezgin, Deveci, Senel, & 
Benli, 2011; Yuksel & Erdem, 2010). Treatment of milk with TGase causes increase 
in viscosity and firmness, and lowers syneresis of yoghurt (Domagała et al., 2013). 
Treatment of milk with TGase has been reported to result in a significant decrease in 
peptide content in yoghurt, but the peptide profile do not change (Yuksel & Erdem, 
2010). Yuksel and Erdem (2010) showed that peptide content significantly decreased 
when TGase is still active during fermentation. To date, there is little research 
reporting the effect of this enzyme on formation of BCM7 and other BCMs. 
However, it is presumed that a major impact of cross-linking by TGase on formation 
of BCMs is unlikely, due to the lack of lysine and glutamine in the BCM sequences 
(Table 1).  
Tyrosinase (EC 1.14.18.1) catalyses oxidation of the phenolic ring of tyrosine to 
diquinones, which further react chemically with each other or free sulfhydryl to form 
covalent cross-linking (Ercili Cura et al., 2010; Monogioudi et al., 2009). Therefore, 
tyrosinase has been applied to increase the firmness of raw milk gels (Ercili Cura et 
al., 2010). To date, there has been no study investigating the effect of tyrosinase on 
the physio-chemical properties of yoghurt. As described in Table 1, the sequences of 
BCMs contain a tyrosine residue that could potentially form cross-linking catalysed 
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by tyrosinase. Therefore, treatment of milk with this enzyme may reduce the 
formation of BCMs and is thus, worthy of future investigation. 
2.5 Analytical methods for identification and quantitation of beta-casomorphin 
5 and beta-casomorphin 7  
Milk and dairy products are complex matrices, containing proteins, lactose, lipids 
and peptides all of which can interfere with separation and detection of target 
peptides such as BCM5 and BCM7, leading to erroneous quantitative and qualitative 
results. Therefore, sample preparation and choice of an analytical method play a 
crucial role in generating accurate and reproducible results (Table 4). Reversed-phase 
high performance liquid chromatography (RP-HPLC) has been used widely in 
separation of peptides and amino acids in food products. RP-HPLC coupled with 
ultra violet (UV) detector has been applied for separation and quantification of 
BCM5 and BCM7 in milk and dairy products (Cieślińska et al., 2007; Latha & 
Mathur, 2001; Muehlenkamp & Warthesen, 1996; Wocior, 2008). In addition, 
HPLC-UV and ion-exchange chromatography have been also used for the analysis of 
BCM7 human milk or in cheese (Jarmolowska et al., 1999; Jarmołowska et al., 
2007). In analysis of peptides, reversed-phase high performance liquid 
chromatography-ultra violet (RP-HPLC-UV) may generate chromatographic peaks 
that are in fact, constituted from the co-elution of multiple peptides with similar 
physical-chemical and spectrophotometric absorption properties to the analytes of 
interest (Muehlenkamp & Warthesen, 1996). This phenomenon can lead to a 
quantitative overestimation of target peptides as demonstrated by Cass et al. (2008). 
In addition, RP-HPLC-UV has low sensitivity to quantify levels of BCM7 found in 
dairy products.  Muehlenkamp and Warthesen (1996) indicated that using RP-HPLC-
UV is not possible to quantify the level of BCM7 below 2 µg/ml of cheese extract. 
Despite these limitations, RP-HPLC-UV is a well-established, relatively cheap, 
simple and “user friendly” analytical technique, thus, its wide popularity. 
In recent years, ELISA has been used for determination of BCM5 and BCM7 in milk 
and fermented milk (Cieślińska et al., 2012; Jarmolowska, 2012; Sienkiewicz-
Szłapka et al., 2009). This analytical technique can quantify the levels of BCM5 and 
BCM7 in cheese at 0.05 and 0.04 ng/mg, respectively. However, the heat treatment 
commonly applied to milk during processing may modify the conformation of BCM7 
and other BCMs, leading to reduction in the binding affinity of the modified BCM7 
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to the antibody and a potential underestimation of the BCM7 level when milk is 
heated at high temperatures (Cieślińska et al., 2012).  
Currently, HPLC coupled with mass spectrometry (MS) represents “the-state-of-the-
art” analytical technique for identification and quantification of peptides in food 
matrices. There are three commonly used MS techniques namely tandem mass 
spectrometry (MS/MS), quadrupole ion-trap mass spectrometry (QIT-MS) and time-
of-flight mass spectrometry (TOF-MS) that have been applied successfully to 
analyse BCM7 and other BCMs in milk and dairy products (Table 4).  
The selectivity and sensitivity of MS/MS, especially when operated in multiple 
reaction monitoring (MRM) mode, allows accurate quantification of BCM5 and 
BCM7 at low levels (sub-ng/mg) in samples containing co-eluting peptides. Using 
this method, Haileselassie et al. (1999) detected BCM7 from an enzyme-modified 
cheese (EMC). More recently, HPLC-MS/MS has been used for quantitative 
determination of BCM5 and BCM7 in cheese, milk, fermented milk, yoghurt, milk-
based infant formulas and extracts of these products after in vitro simulated gastro-
intestinal digestion. BCM7 was quantified to a level as low as 0.01 ng/mg (De Noni, 
2008; De Noni & Cattaneo, 2010). In other studies, BCM9 was detected in the water-
soluble extracts of an Italian goat cheese (Rizzello et al., 2005). 
QIT-MS mass spectrometry can perform multiple fragmentation spectra (MSn), 
allowing to some extent, structural elucidation of unknown peptides. Similar to 
MS/MS, QIT-MS operated in single reaction monitoring (SRM) mode can be also 
used for quantification of BCM5 and BCM7. Juan-Garcia et al. (2009) examined 
BCMs in cheese and milk using a nano electrospray QIT-MS providing a fast and 
easy means of analysis of these compounds in different matrices. The main 
fragmentation pathways for BCMs and structures for the major fragment ions 
recorded in the MSn spectra were also reported. Most recently, Thiri et al. (2012) 
used a hybrid triple quadrupole linear ion trap mass spectrometer operated in MRM 
mode to quantify BCM7 in milk at a level of 0.2 ng/ml.   
TOF-MS is a high accuracy and high resolving power mass spectrometry technique. 
Using this technique can unequivocally identify unknown compounds in complex 
matrices. This is usually achieved by combining elemental formula information (i.e. 
CxHyOzNj…) from experiments of high mass accuracy with structural information 
from fragmentation experiments. Using HPLC-TOF-MS, Toelstede and Hofmann 
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(2008) identified BCM9 and BCM10 in the water-soluble extract of Gouda cheese. 
TOF-MS also allowed Cass et al (2008) to demonstrate that a peak previously 
analysed by HPLC-UV was in fact erroneously identified as BCM7.  
In conclusion, RP-HPLC coupled with different mass analysers is a suitable method 
for quantifying BCM7 and other BCMs in milk and dairy products at low levels 
(sub-ng/g or ng/mL).  
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Table 4. Methods used for identification and quantification of BCMs  
Beta-casomorphins 
 
Matrix Sample preparation 
Analytical 
technique 
Limits of 
detection 
References 
BCM7 Cow milk 
Extraction 
chloroform/methanol, 
centrifugation,  lyophilisation 
and  purification by solid-phase 
extraction (SPE) using C18 T  
cartridge 
ELISA Not reported Cieślińska et al. (2012) 
BCM5 and BCM7  Cheese 
Extraction chloroform/ 
methanol,  centrifugation, fat 
removal,  and lyophilisation and  
purification by SPE using C18T  
cartridge 
ELISA 
11.10-3 
µg/mL 
BCM5 
13.10-3 
µg/mL 
BCM7 
Sienkiewicz-Sz1apka et 
al. (2009) 
BCM7 
Yoghurt, other 
fermented milk 
Centrifugation and 
ultrafiltration  
ELISA Not reported Jarmolowska (2012) 
BCM7 Cheese 
Extraction 
chloroform/methanol, gel 
filtration 
Ion exchange 
chromatography 
Not reported 
Jarmołowska et al., 
(1999) 
BCM3, BCM4, Cheese Extraction chloroform/ HPLC-UV 2 µg/mL Muehlenkamp and 
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BCM5, BCM6 and 
BCM7 
methanol,  centrifugation, fat 
removal,  and lyophilisation 
(220, 254, 280 
nm) 
(BCMs) Warthesen (1996) 
BCM5 and BCM7 
Human 
colostrum, 
milk 
Extraction methanol/chloroform 
followed by shaking, 
centrifugation, lyophilisation 
and purification on C18 SPE 
cartridge 
HPLC-UV 
(280 nm) 
0.8  µg/mL 
BCM5 
0.6  µg/mL  
BCM7 
Jarmołowska et al., 
(2007) 
BCM7, BCM9 and 
BCM13  
Cow milk 
Enzymatic digestion  
Chromatographic 
fractionation/purification on 
SPE cartridge 
HPLC-UV 
(280 nm) 
 
Not reported 
Jinsmaa and Yoshikawa 
(1999) 
BCM7 Cow milk 
Extraction chloroform/ 
methanol followed by 
centrifugation, lyophilisation 
and purification on SPE 
cartridge 
HPLC-UV Not reported  Cieślińska et al.(2007) 
BCM5 
High protein 
formulas 
Extraction chloroform/ 
methanol followed by  
centrifugation, lyophilisation 
and purification on SPE 
cartridge 
HPLC-UV Not reported  Wocior (2008) 
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BCM4 Fermented milk 
Extraction chloroform/ 
methanol,  
absorption/desorption on 
charcoal/ evaporation  
HPLC-UV 
(220 nm) 
LC-MS 
MS scan (200-
800 m/z) 
Not reported 
Matar and Goulet 
(1996) 
BCM5 and BCM7 
 
Milk-based 
infant formulas 
 
milk coagulation, 
centrifugation, filtration and  
lyophilisation 
HPLC-MS/MS 
MRM transitions 
(m/z) 
BCM5 
580.3408.2; 
286.0 
BCM7 
790.3381.1; 
530.2 
Not reported De Noni (2008) 
BCM5 and BCM7 
 
Cheese, milk, 
yoghurt, infant 
formulas, dried 
milk  
Centrifugation and 
ultrafiltration  
HPLC-MS/MS 
MRM transitions 
(m/z) 
BCM5 
580.3408.2; 
286.0 
BCM7 
Not reported 
De Noni and Cattaneo 
(2010) 
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790.3381.1; 
530.2 
BCM7 Pasteurised milk 
Centrifugation followed by 
filtration with molecular weight 
cut off filter 
UPLC-hybrid 
triple quadruple 
linear ion trap 
MS, MRM 
transition 
0.2ng/ml Thiri et al. (2012) 
BCM5, BCM7, 
BCM10 and BCM11 
Cheese and milk 
Extraction, fat removal, 
purification on polymeric SPE 
cartridge 
HPLC-QIT-MS 
Q-IT in full scan 
and MSn 
Not reported 
Juan-Garcia et al. 
(2009) 
BCM7 
Enzyme 
modified cheese 
Centrifuge, methylene chloride 
and water,  concentrated by 
Speed Vac 
HPLC-API-MS Not reported 
Haileselassie et al. 
(1999) 
BCM9 Cheese 
Centrifugation, filtration 
through Whatman paper and 
0.22 µm membrane.  
HPLC-QIT-MS 
operated in MS 
scan and MS/MS 
full scan 
Not reported Rizzello et al. (2005) 
BCM9 Cheese 
Homogenisation with water 
following by centrifuge,  
dialysation, lyophilisation  
HPLC-GPC 
Fast atom 
bombardment-
MS 
Not reported Saito et al. (2000) 
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BCM7 Cheese Coker (2002) 
HPLC-MRM-
MS/MS 
Not reported Norris et al. (2003) 
BCM9  and BCM10 Cheese 
Extraction with deionised water, 
centrifugation, paper filtration, 
lyophilisation 
HPLC-TOF-MS 
LC-MS/MS 
Not reported 
Toelstede and Hofmann 
(2008) 
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2.6 Papers 
This review has been published in the following journal article: Duc Doan Nguyen, 
Stuart Keith Johnson, Francesco Busetti, and Vicky Ann Solah (2015). Formation 
and degradation of beta-casomorphins in dairy processing. Critical Reviews in Food 
Science and Nutrition 15(14), 1955-1967.  
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CHAPTER 3: DEVELOPMENT OF AN ANALYTICAL METHOD FOR THE 
ACCURATE DETERMINATION AND QUANTIFICATION OF BETA-
CASOMORPHIN 5 AND BETA-CASOMORPHIN 7 IN YOGHURT 
3.1 Introduction 
Yoghurt is a complex food matrix containing proteins, sugars, fatty acids and 
peptides that can interfere in detection of analytes of interest. In addition, yoghurt 
may also contain a number of peptides with different sizes and different sequences, 
but similar physicochemical properties, which could cause overestimation of results 
for a target peptide due to co-eluting with other peptides when analysed by 
conventional HPLC coupled with UV-Vis detection (Sienkiewicz-Szłapka et al., 
2009). In recent years, a number of studies have reported the presence of ACE-I 
peptides (Donkor et al., 2007; Kunda et al., 2012), antioxidant peptides (Sabeena 
Farvin et al., 2010) and antimicrobial peptides (Poyrazoglu Coban et al., 2012) in 
yoghurt. The majority of these peptides originate from beta-caseins (β-CNs). 
Furthermore, yoghurt has also been reported to contain the opioid peptides known as 
BCMs (Jarmolowska, 2012).   
BCM5 and BCM7 are two important BCMs. Their presence has been extensively 
studied in milk and fermented milk products due to their potential involvement in 
human chronic diseases. Many studies have reported the occurrence of BCM7 or 
BCM5 in different types of cheese (De Noni & Cattaneo, 2010; Norris et al., 2003; 
Sienkiewicz-Szłapka et al., 2009). However, the presence of these two peptides in 
yoghurt and milk has been disputed over the years, possibly due to lack of analytical 
method sensitivity and selectivity.  In addition, food processing may alter the BCM 
content. Recently, ELISA has been applied to quantify BCM7 in commercial yoghurt 
and other fermented milk products, milk and heated milk. The level of the peptide 
found was between 29 and 54 ng/mg protein in yoghurt and fermented milk 
(Jarmolowska, 2012); from 1.1 to 2.1 ng/mL in milk and from 2.9 to 7.4 ng/mL in 
heated milk (Cieślińska et al., 2012). However, there has been no study reporting 
analysis of BCM5 in yoghurt by ELISA.  
Using high performance liquid chromatography-tandem mass spectrometry (HPLC-
MS/MS), De Noni and Cattaneo (2010) detected neither BCM5 nor BCM7 in 
yoghurt and milk. Nevertheless, the latter was found in milk when analysed by 
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HPLC-quadrupole ion-trap mass spectrometry (HPLC-QIT-MS) (Juan-García et al., 
2009) or ultra-performance liquid chromatography (UPLC) coupled with hybrid 
triple quadrupole linear ion trap mass spectrometry (Thiri et al., 2012). 
In LC-MS quantitative analysis, the choice of the calibration technique plays an 
important role in the accuracy and precision (i.e. trueness) of the analytical results. 
Serial mixtures of standard solutions for external calibration have previously been 
used for the simultaneous quantification of BCM5 and BCM7 (De Noni & Cattaneo, 
2010; Juan-García et al., 2009). However, this approach could result in ion 
suppression that ultimately leads to a decrease in the response of target analytes 
(Jessome & Volmer, 2006) and therefore, resulting in an underestimation of content 
of the analytes in the sample. When using external standards however, it is necessary 
for the calibration samples to be identical in composition to test samples to 
compensate fully for any matrix effects (Jessome & Volmer, 2006). This requirement 
is a challenging task in the case of analysis of complex matrices such as milk and 
yoghurt.   
Alternatively, using deuterated homologues as internal standards is a technique 
allowing easy identification and quantification of target analytes in complex 
matrices. Stable isotope-labelled compounds allow compensation for matrix effects 
and loss of target analytes during sample preparation, leading to significant reduction 
of data variability and improvement of accuracy and precision of results (Jessome & 
Volmer, 2006). To date, only one study has reported the application of stable 
isotope-labelled BCM as the internal standard for the quantitative determination of 
BCM7; however this study was performed on plasma, not on milk or milk products 
(Song, Zaw, Amirkhani, Clarke, & Molloy, 2012). Currently, no study has been 
reported on the use of deuterated homologues for simultaneous determination of 
BCM5 and BCM7 in yoghurt or milk.       
In this study, a highly sensitive and selective LC-MS/MS method was developed for 
the simultaneous determination of BCM5 and BCM7 in yoghurt. The successful 
validated method has then been applied for the identification and quantitation of 
these two peptides in commercial and laboratory scale manufactured yoghurts 
(Chapters 4, 5 and 6). This method has also been used for the simultaneous analysis 
of BCM5 and BCM7 in different types of milk (Chapter 4).  
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3.2 Materials and methods 
3.2.1 Chemicals and materials 
UHT milk used for production of yoghurt was supplied by A2 Dairy Products 
Australia Pty Ltd (Botany, NSW, Australia). Yoghurt culture (YO-MIXTM) is a 
freeze-dried powder containing two common LAB, L. delbrueckii spp. bulgaricus 
and S. thermophilus produced by Danisco (France). Standards of BCM5 (purity 
97.8%), BCM7 (purity >98.7%) and the deuterated standards [2H10] BCM5 (BCM5-
d10) and [2H10] BCM7 (BCM7-d10) - deuterium enrichment > 99%, 2H enrichment 
at phenylalanine position - were purchased from Auspep Pty. Ltd. (Tullamarine, 
VIC, Australia). The ultrapure water was purified using an IBIS Technology (Perth, 
WA, Australia) Ion Exchange System followed by a Elga Purelab Ultra System 
(Sydney, NSW, Australia). Methanol (ChromAR HPLC grade) was purchased from 
Mallinckrodt (New Jersey, USA); formic acid (purity 99%) was purchased from 
Ajax FineChem (Sydney, NSW, Australia). All chemicals and solvents were of 
HPLC-grade.  
3.2.2 Solutions and calibration standards 
Stock solutions of BCM5, BCM7 and deuterated standards BCM5-d10 and BCM7-d10 
(1 mg/mL) were prepared by dissolving 5 mg of each compound in a 5 mL of 
ultrapure water and then dispensed evenly into HPLC vials and stored -20 οC. 
Working stock solutions (10 ng/µL and 25 ng/µL) of BCM5, BCM7; and deuterated 
standards BCM5-d10, BCM7-d10 (10 ng/µL) were prepared by diluting stock 
solutions in ultrapure water. Serial mixed standard solutions of BCM5 and BCM7 in 
the range 0.01-25 ng/μL, spiked with 1 ng/µL of deuterated standards, were prepared 
from the working stock solutions. The working solutions and serial mixed standard 
solutions were prepared freshly before each analysis.  
3.2.3 Production of yoghurt 
One litre of UHT milk was heated to 43 οC in an incubator. The warm milk was 
inoculated with 0.003% (w/v) of YO-MIXTM and mixed thoroughly. The inoculated 
milk was incubated at 43 οC until pH reached to the value of 4.6. After fermentation, 
the yoghurt was cooled down and stored at 4 οC overnight. This yoghurt was used for 
the subsequent development and validation of the analytical method.  
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3.2.4 Extraction of water soluble peptides 
The extraction was performed as described in Donkor et al. (2007) with some 
modifications. Yoghurt (10.0000 ± 0.0001 g) was accurately weighted into a 
centrifuge tube and then centrifuged at 15,000×g at 4 οC for 30 min (Centrifuge 5810 
R, Eppendorf, Hamburg, Germany). The supernatant was decanted into a clean 
centrifuge tube and then drops of 1M HCl (or 1M NaOH) slowly added to adjust to 
pH 4.6. The pH adjusted supernatant was allowed to stand for 5 min at room 
temperature to completely precipitate caseins then centrifuged at 14,000×g for 20 
min at 4 οC. The supernatant was collected by decantation and subsequently filtered 
through a 0.45 µm membrane filter. Evaporation of the filtered extract to a final 
volume of 1 mL was carried out using a gentle nitrogen flow over the extract surface. 
The concentrated extract was filtered through a 0.45 µm membrane filter directly 
into an HPLC vial before injection into the LC system. The extraction was performed 
in triplicate. 
3.2.5 Liquid chromatography-tandem mass spectrometry conditions  
Experiments were performed using an 1100 Agilent LC system (Palo Alto, CA, 
USA) coupled with a Micromass (Manchester, UK) Quattro Ultima triple quadrupole 
mass spectrometer fitted with an electrospray ionisation source operated in positive 
mode. Chromatographic separation of the analytes and the deuterated homologues 
was carried out using a Kinetex C18 LC-MS column (100 mm × 2.1 mm, 2.6 μm, 
100 Å, Phenomenex, Sydney, Australia) by injection of 5 μL of exract at a flow rate 
of 100 μL/min. The column was protected by a KrudKatcher Ultra HPLC in-line 
filter (0.5 µm depth filter x 0.004 inch ID). The mobile phase consisted of methanol 
(MeOH) (A) and ultrapure water (B), both containing 0.1% of formic acid. The 
chromatography runs commenced with 30% (A) for 3 min, followed by a 15 min 
linear gradient to 100% (A). The mobile phase remained at 100% (A) for 15 min to 
elute analytes from the column. Afterwards, the initial conditions were re-established 
within 1 min and the column re-equilibrated for 15 min before injecting the next 
sample. To minimise potential carryover, the needle of the injector was rinsed for 30 
seconds with MeOH before and after each injection. 
Optimum MS signals were achieved by tuning the ESI capillary and cone voltages to 
3.25 KV and 25 V, respectively. Hexapole1, aperture and hexapole2 were set to 0.0 
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V, 0.1 V and 0.2 V, respectively. Desolvation temperature and source temperature 
were set to 325 °C and 135 °C, respectively. Cryogenic liquid nitrogen gas (BOC 
Gases, Perth, Australia) was used as desolvation and nebulizer gas; cone gas flow 
was set to 40 L/h, while the desolvation gas flow was set to 765 L/h. High purity 
argon (99.997% purity) (BOC Gases, Perth, Australia) was used as collision gas (P = 
2.7 × 10-4 kPa). Both quadrupoles (Q1 and Q3) were set at unit mass resolution; ion 
energy on Q1 and Q3 was set to 1.0, while the multiplier was set at 750 V. 
Quantification was performed by calculating the ratio of the peak area of the analytes 
to the peak area of the corresponding deuterated standards. Concentrations were 
calculated by QuanLynx 4.0 software comparing the peak area ratios from the 
extracts to peak area ratios from the calibration standards.  
3.2.6 Validation of the analytical method 
Parameters of the analytical method that need to be validated consisted of 
instrumental linearity, instrumental detection limits (IDLs) and instrumental 
quantification limits  (IQLs), peak identification criteria (retention time and MRM 
ratio), accuracy, precision, inter-day reproducibility, method  limits of detection 
(LODs), method limits of quantitation (LOQs) and matrix effects.  
3.2.6.1 Liquid chromatography-tandem mass spectrometry performance 
Serial standard solutions were repetitively injected into the LC-MS/MS system to 
assess its performance. The determination of linear range was performed by 
analysing standard solutions in concentrations from 0.01 to 25 ng/µL (Section 3.2.2). 
Low concentrations of standard solutions were used for evaluation of IDLs and IQLs.  
IDLs and IQLs were calculated at signal-to-noise (S/N) ratio of 3 and S/N of 10, 
respectively. Standard solution at 1 ng/µL was used to determine the variability of 
the MRM ratio and of the retention time (repeat injection, n=15).  
3.2.6.2 Accuracy and precision 
Accuracy and precision of the method were assessed by a recovery study of BCM5 
and BCM7 spiked in yoghurt. Yoghurt samples (10.000 ± 0.0001 g) were spiked 
with standard solutions of BCM5 and BCM7 at five different levels of concentration 
(1, 10, 100, 1000 and 2500 ng/g) in triplicate. In addition, the internal standards at a 
concentration level of 100 ng/g were also added to the yoghurt samples.  Accuracy 
and precision were expressed as recovery relative to the internal standards (%) and 
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relative standard deviation (%RSD), respectively. Blank yoghurt samples (10.0000 ± 
0.0001 g) in triplicate with the internal standards added at a concentration of 100 
ng/g were used for QA/QC purpose. All samples were extracted as described in 
Section 3.2.4 and injected into the LC-MS/MS system with conditions as described 
in Section 3.2.5.   
3.2.6.3 Inter-day reproducibility 
Inter-day reproducibility was determined by repeated analysis (n=3) on two 
consecutive days of three yoghurt samples spiked with BCM5 and BCM7 at levels of 
10, 100 and 1000 ng/g. Inter-day reproducibility was expressed as %RSD.  
3.2.6.4 Method limit of detection and limit of quantitation 
Yoghurt samples spiked with standard BCM5 and BCM7 at the low levels of 1 ng/g 
and 10 ng/g were used to estimate LODs and LOQs. LODs and LOQs were 
calculated from the concentration equivalent to S/N of 3 and S/N of 10, respectively, 
on smoothed chromatographic traces (Busetti, Linge, Blythe, & Heitz, 2008).  
3.2.6.5 Evaluation of matrix effects  
The matrix effect was assessed by comparison of response of the analytes in ultra-
pure water with that in yoghurt extract at the same concentration. Blank yoghurt 
extracts and ultra-pure water were added the mixture solution of BCM5 and BCM7 
at 1,000 ng/mL and then analysed by LC-MS/MS with above described conditions. 
The matrix effect was calculated as followed (Eq.1): ME (%) = As −A𝑚𝑚
As
 × 100  (1) 
Where: - ME is the matrix effect (%) 
 - As is the area of BCM5 or BCM7 added in ultrapure water (standard 
solution)  
 - Am is the area of BCM5 or BCM7 added in a yoghurt blank extract 
(matrix). 
3.3 Results and discussions 
3.3.1 Optimisation of MS/MS conditions 
The mixture of standard solution of BCM5 and BCM7 at level of 5 ng/mL in 
MeOH:H2O (50:50) containing 0.1% of formic acid was used to optimise: 1) 
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formation of protonated parent ions minimising secondary adducts in the ion source; 
2) fragmentation of selected parent ions (MS/MS) in the collision cell  and 3) 
detection of product ions in multiple reaction monitoring (MRM) mode.  
The molecular weight of BCM5, BCM7 and their deuterated standards BCM5-d10 
and BCM7-d10 are 579.65, 789.93, 590 and 800 Da, respectively (Auspep Pty. Ltd. 
Victoria, Australia). Therefore, initial experiments were performed in MS scan mode 
(Scan range: 50-1000 m/z). It could be observed that most intense precursor ions in 
the presence of 0.1% of formic acid were the proton adducts [M+H]+. In addition, 
other precursor ions such as sodium or MeOH adducts usually present in non-
acidic/methanolic solutions were substantially weaker.  Thus, [M+H]+ precursor ions  
(Table 5) were selected for fragmentation in product ion scan mode in further 
MS/MS experiments. The MS/MS spectra of BCM7 have been reported by De Noni 
(2008). The fragmentation spectra of BCM5 and the main product ions identified in 
the present study are showed in Fig. 6. 
 
Figure 6. Product ions spectra showing the fragmentation of BCM5 obtained at 
variable collision energy values. Tyrosine (Tyr); proline (Pro); phenylalanine (Phe)  
and glycine (Gly) are indicated in the chemical structure of BCM5  
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After optimisation of the collision energy, which controls the degree of 
fragmentation of the parent ions in the collision cell (Q2), the most intense 
characteristic transitions were identified from the product ion spectra (data not 
shown). Each BCM and its internal standard was identified using two MRM 
transitions, which means that one parent ion fragmented into two product ions (Table 
5). This approach provides four identification points, which are sufficient to fulfil the 
criteria to identify and confirm the presence of a target analyte in food matrices (EC, 
2002). In addition, the presence of the target analytes was also confirmed by 
monitoring the MRM ratio and retention time (tR) against standard solutions (Table 
6). 
Table 5. Precursor and product ions, and collision energy values optimised for the 
analysis of BCM5 and BCM7 under ESI(+) MS/MS in MRM mode. MRM 
transitions were grouped in one window. Dwell time was 80 ms for all the transitions 
monitored.  
Compounds 
Precursor ions 
(m/z) 
Product ions 
(m/z) 
Collision energy 
(arbitrary units) 
BCM5 580.4 
173.3a 
408.4 
30 
25 
BCM5-d10 590.4 
173.3a 
418.4 
30 
25 
BCM7 790.7 
229.3a 
530.4 
50 
35 
BCM7-d10 800.7 
229.3a 
540.4 
50 
35 
a The product ions from the transitions used for quantification  
3.3.2 Instrumental performance and peaks identification criteria 
For assessment of LC-MS/MS instrument performance and identification of peaks of 
target analytes, standard solutions of BCM5 and BCM7, and their internal standards 
BCM5-d10 and BCM7-d10 at level of 1 ng/µL were injected into the LC-MS/MS 
system. The LC-MS/MS chromatogram is showed in Fig. 7. 
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Figure 7. A typical LC-MS/MS chromatogram of BCM5, BCM7 and their deuterated 
standards (BCM5-d10 and BCM7-d10) 
The linear range was tested using calibration standards in range between 0.01 ng/μL 
(0.05 ng on column) and 25 ng/μL (125 ng on column). The calibration curve of 
ratios of peak area of analyte to peak area of deuterated standard against analyte 
concentrations was constructed. Values of regression coefficient (R2) for both BCM5 
and BCM7 were higher than 0.9980 in the range between 0.05 and 50 ng on column 
(Table 6), indicating good linearity in the range of concentrations tested. IDLs for 
BCM7 and BCM5, estimated at S/N of 3, were 0.007 and 0.010 ng on column, 
respectively. IQLs for BCM7 and BCM5, estimated at S/N of 10, were 0.024 and 
0.036 ng on column, respectively. MRM ratio variability (%RSD) and tR variability 
(SD) were less than 8.8% and less than 0.2 min (12 s), respectively, indicating 
reproducible fragmentation of the parent ions in the collision cell and a reproducible 
chromatographic separation.  
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Table 6. Instrumental performance parameters obtained by repeat injections of 
standard solutions into the LC-MS/MS system.  
Compounds Linear range a  R2 
IDLa 
S/N = 3 
IQLa 
S/N = 10 
MRM ratio 
(±%RSD) 
tR 
(min±SD) 
BCM5 0.05–50 0.9985 0.010 0.036 3.0±7.8 18.2±0.2 
BCM7 0.05–50 0.9986 0.007 0.024 2.6±8.8 20.6±0.1 
a ng on column 
IDL: instrumental detection limit; IQL: instrumental quantitation limit; MRM: multiple reaction 
monitoring; tR: retention time. 
3.3.3 Accuracy and precision 
In order to calculate accuracy and precision of the method, yoghurt samples were 
spiked with the mixture of standard solutions of BCM5 and BCM7 at 5 different 
levels of concentration levels (Table 7). Accuracy was in the range between 95 and 
106% for BCM5 and between 103 and 109% for BCM7 (Table 7). Relative standard 
deviation ranged between 1-6% for BCM7, and 1-7% for BCM5, with the exception 
of the value for BCM5 spiked at the concentration of 1 ng/g where relative standard 
deviation was higher (Table 7).  
Table 7. Recovery and precision study for BCM5 and BCM7 
Compounds 
Spiked levels 
(ng/g)  
Recovery   
(%, n=3) 
Precision  
 (%RSD, n=3) 
BCM5 
1 106 16 
10 104 7 
100 106 2 
1000 95 2 
2500 97 1 
BCM7 
1 103 5 
10 109 4 
100 107 6 
1000 106 1 
2500 104 1 
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3.3.4 Inter-day reproducibility 
The inter-day reproducibility of the method was determined by repeated 
measurements of yoghurt spiked with three different levels of BCM5 and BCM7 on 
two consecutive days (Table 8). Relative standard deviation ranged between 2.0 and 
6.4% for BCM5 and between 3.2 and 6.1% for BCM7 (Table 8), indicating good 
inter-day reproducibility of the adopted analytical method.  
3.3.5 Method limits of detection and method limits of quantitation 
Calculation of LODs and LOQs were based on analysis of BCM5 and BCM7 in 
yoghurt samples spiked with these two peptides at levels of 1 ng/g and 10 ng/g. 
LODs were 0.5 ng/g and 0.25 ng/g for BCM5 and BCM7, respectively. LOQs for 
BCM5 and BCM7 were 1.7 ng/g and 0.85 ng/g, respectively. To date, LODs and 
LOQs for BCM5 and BCM7 in yoghurt have not been previously reported, so it is 
difficult to compare these results with previously published ones.  
3.3.6 Evaluation of matrix effects  
In the present study, matrix effects were corrected with the inclusion of deuterated 
homologues; this approach is by far the most effective method to account for matrix 
effects as the analytes and the corresponding co-eluting deuterated homologues are 
subject to almost identical environments. Matrix effects were responsible for causing 
about 26% and 40% signal suppression for BCM5 and BCM7, respectively. It is 
possible to reduce signal suppression using additional clean-up of samples (e.g. on-
line or off-line SPE). This approach could result in improvement of LODs.   
3.4 Conclusions 
The results presented in this chapter demonstrate that preparation of samples using 
high speed centrifugation and 0.45 µm membrane filters followed by analysis by LC-
MS/MS is a sensitive, selective and robust analytical protocol that can be applied for 
the simultaneous determination of BCM5 and BCM7 in a complex matrix, such as 
yoghurt. The use of isotope labelled homologues as the internal standards in the 
analytical method produced the highest confidence in the quantitative assessment of 
BCM5 and BCM7 levels in complex matrices, effectively correcting for 1) analyte 
loss encountered during sample extraction and 2) matrix effects encountered during 
the analysis of the samples. 
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Table 8. Inter-day reproducibility data determined by repeating measurements on two different days of yoghurt samples spiked at three 
different levels of BCM5 and BCM7 
Compounds 
spiked level  
(ng/g) 
Analysis (day 1, n=3) 
(ng/g) 
Analysis (day 2,n=3) 
(ng/g) 
Average 
(ng/g) 
Inter-day reproducibility 
(%RSD) 
BCM5 
10 10.4 11.2 10.8 6.4 
100 106 106 106 2.0 
1000 950 1000 974 3.6 
 
BCM7 
10 10.7 11 10.8 6.1 
100 110 111 110 3.4 
1000 1041 1077 1059 3.2 
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The method reported in this chapter has been used for the determination of BCM5 
and BCM7 in commercial yoghurts as well as yoghurts prepared in our laboratory 
(see Chapters 4, 5 and 6 for more information). In addition, the present method has 
been also modified to allow the measurement of BCM5 and BCM7 in milk (see 
Chapter 4 for more information).  
3.5 Papers 
A part of content of this chapter has been published in the following journal article: 
D. D. Nguyen, V. A. Solah, S. K Johnson. J. W. A Charrois and F. Busetti (2014). 
Isotope dilution liquid chromatography–tandem mass spectrometry for simultaneous 
identification and quantification of beta-casomorphin 5 and beta-casomorphin 7 in 
yoghurt. Food Chemistry 146, 345-352. 
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CHAPTER 4 IDENTIFICATION AND QUANTIFICATION OF BETA- 
CASOMORPHINS IN COMMERCIAL MILK PRODUCTS  
4.1 Introduction 
Bovine milk has been found to contain β-CN with 13 variants (Kamiński et al., 2007) 
that differ at various amino acid positions (Fig. 3), among which, β-CN A1 and β-CN 
A2 variants are commonly found in bovine milk. The ratio of β-CN A1 and β-CN A2 
variants in milk depends on the cow breed from which the milk was obtained. 
Holstein-Friesian cows produce milk containing higher levels of β-CN A1 than β-CN 
A2 variant (Tailford et al., 2003), while Guernsey and Jersey breeds predominantly 
produce β-CN A2 variant (Bell et al., 2006; Merriman, 2009). Milk that contains 
both variants in equal amount is known as “normal” milk, while milk containing β-
CN A2 variant only is known as A2 milk (Woodford, 2007). 
In Australia, the most common dairy cow breed is Friesian Holstein, accounting for 
65-70% of dairy cows. Other breeds include the Jersey, the Holstein/Jersey cross, 
Brown Swiss and Ayrshire. In addition, local breeds such as the Australian Red and 
the Illawarra are also important in dairy industry in Australia (Dairy Australia, 2013). 
In recent years, consumers and the media in Australia have been interested dairy 
products containing the majority of β-CN A2 variant, which was reported to not 
release BCM7 (De Noni, 2008; Haq, Kapila, & Kapila, 2015) or if formed, it will be 
at a very low rate (Korhonen & Marnila, 2013). Therefore, this milk should either not 
contain this peptide or contain it at very low level. Furthermore, intake of this milk 
should not release BCM7 during digestion and thus A2 milk is reported by 
manufacturers to possibly assist in digestion well-being. However, there has been no 
previous study of Australian milk on the concentration BCM5 and BCM7 in β-CN 
A2 variant-rich milk or other normal milk.   
Currently, identification of BCM5 and BCM7 in milk, yoghurt and milk powder has 
also been equivocal. Several studies have reported BCM7 in milk, yoghurt and milk 
powder (Cieślińska et al., 2012; Jarmolowska, 2012; Juan-García et al., 2009; Thiri 
et al., 2012) while BCM5 has been reported in infant formula that contains modified 
skimmed cow milk (Jarmołowska et al., 2007) and high protein supplement 
containing milk protein (Wocior, 2008). However, neither BCM5 nor BCM7 was 
detectable in infant formulas containing skim milk (De Noni & Cattaneo, 2010).  
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The aim of study in this chapter was to investigate the levels of BCM5 and BCM7 in 
commercial yoghurt, pasteurised milk and skim milk powder using the highly 
sensitive method of LC-MS/MS; the development of which was reported in Chapter 
3. Furthermore, confirmation of the presence of BCM5 and BCM7 in some milk 
samples was performed by LC-HRMS.  
4.2 Materials and methods 
4.2.1 Materials and chemicals 
Ten samples of commercial yoghurt, in December 2012, and 14 samples of 
pasteurised milk, from May to July 2014, produced from Australian milk by different 
manufacturers, were purchased from supermarkets around Australia. A skim milk 
powder supplied by A2 Dairy products Australia Pty Ltd was reported to be 
pasteurised before thermal evaporation and then spray drying. All products were 
randomly coded before sampling (Table 9). Other materials and chemicals used in 
this investigation have been previously described in Section 3.2.1.  
4.2.2 Methods 
4.2.2.1 Preparation of yoghurt extracts 
The extraction of water soluble peptides from commercial yoghurt was carried out as 
described in Section 3.2.4. 
4.2.2.2 Preparation of milk and skim milk powder extracts  
The extraction of water soluble peptides from pasteurised milk was performed as 
follows: 25.0000 g (±0.0001 g) of pasteurised milk and 25.0000 g (±0.0001 g) of 
reconstituted skim milk (1.3/10: skim milk powder/water–w/v) were spiked with 500 
ng of a mixture of BCM5-d10 and BCM7-d10. In addition, a separate 25.0000 g 
(±0.0001 g)  sample of pasteurised  or reconstituted milk were each spiked with 100 
ng of a mixture of BCM5 and BCM7 plus 500 ng of  the mixture of BCM5-d10 and 
BCM7-d10; these samples were used as quality control samples (QCs). All samples 
were gradually acidified with 1 M HCl to pH 4.6 and then left at room temperature 
for 10 min for precipitation of caseins, followed by centrifugation at 15,000 × g for 
30 min at 4 °C. The supernatants were decanted into tubes and then the tubes were 
re-centrifuged at 14,000 ×g for 20 min at 4 °C. 
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Table 9. Specification of milks and yoghurts and milk powder used for investigation of determination of BCM5 and BCM7 contents 
Products Location of process Type of milk 
Expiration time 
(day) a 
Protein content b  
Strains of bacteria c 
Total β-CN A2 Β-CN A1 
Yoghurt 
Yg 1 WA, Australia Cow milk 30 46 n.a n.a S. thermophilus and L. bulgricus 
Yg 2 WA, Australia Cow milk 13 46 n.a n.a S. thermophilus and L. bulgricus 
Yg 3 WA, Australia Cow milk 18 58 n.a n.a S. thermophilus, L. acidophilus and Bifidobacterium 
Yg 4 WA, Australia Cow milk 16 51 n.a n.a S. thermophilus, L. bulgricus, L. acidophilus and 
Bifidobacterium 
Yg 5 WA, Australia Cow milk 19 102 n.a n.a S. thermophilus, L. bulgricus, L.acidophilus, bifidus and 
L. casei 
Yg 6 WA, Australia Cow milk 30 47 n.a n.a S. thermophilus and L. bulgricus 
Yg 7 WA, Australia Cow milk 22 50 n.a n.a S. thermophilus, B. lactis and L. acidophilus 
Yg 8 WA, Australia Cow milk 22 46 n.a n.a L. acidophilus, bifidus and L. casei 
Yg 9 WA, Australia Cow milk 16 36 n.a n.a S. thermophilus, L. acidophilus and Bifidobacterium 
Yg 10 WA, Australia Cow milk 14 50 n.a n.a L. acidophilus, Bifidobacterium and Lactobacillus GG 
Milk 
PM 1 South Brisbane, QLD Cow milk 5 36 n.a n.a - 
PM 2 South Brisbane, QLD Cow milk 5 32 n.a n.a - 
PM 3 Wagga Wagga, NSW Cow milk 4 34 n.a n.a - 
PM 4 Harvey, WA Cow milk 12 33 n.a n.a - 
PM 5 Margaret River, WA Cow milk 9 33 n.a n.a - 
PM 6 Northcliffe, WA Cow milk 8 32 n.a n.a - 
PM 7 Perth, WA Cow milk 13 31 10 n.a - 
PM 8 Perth, WA Cow milk 2 33 n.a n.a - 
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PM 9 South Brisbane, QLD Cow milk 3 36 n.a n.a - 
PM 10 Manning Valley, 
NSW 
Cow milk 4 31 n.a n.a - 
PM 11 Penrith, NSW Cow milk 4 34 7 4 - 
PM 12 Docklands, Vic Cow milk 4 34 n.a n.a - 
PM 13 Riverina, NSW Cow milk 7 31 10 n.a - 
PM 14 Perth, WA Cow milk 12 31 10 n.a - 
Skim milk powder 
SMP Keysborough, VIC  Cow milk 30 n.a n.a n.a - 
QLD: Queensland; NSW: New South Wale; Vic: Victoria; WA: Western Australia 
Yg: Yoghurt; PM: Pasteurised milk; SMP: Skim milk powder 
n.a.: not available 
a Days to expiration on the day of extraction 
b Protein content reported by manufacturers: Yoghurt  (mg/g), milk (mg/mL) 
c Name of strains of bacteria showed on the labels of the products 
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The supernatants were then filtered through Whatman filter paper n° 541 before 
clean-up by SPE. The SPE cartridges (Oasis HLB, 500 mg/6mL, Waters Tokyo, 
Japan) were conditioned with 9.5 mL of MeOH followed by 9.5 mL of ultrapure 
water. The filtrates were diluted with 150 mL of ultrapure water, mixed thoroughly 
and then loaded onto the conditioned SPE cartridges. The loaded SPE cartridges 
were washed with 3.5 mL of 10% MeOH in ultrapure water (v/v) to elute 
interferences, followed by drying under vacuum of 20 mmHg for 10 min at room 
temperature to remove excess moisture. Retained peptides were then eluted using 
3×4 mL of MeOH. A delay of 1 min between each aliquot of solvent was used to 
ensure that the stationary phase was efficiently soaked with the eluting solvent. The 
peptide-containing extracts were evaporated at 30 °C under a gentle stream of 
nitrogen using a dry block heater with nitrogen blowdown to a final volume of 0.5 
mL. Extracts were then transferred into brown glass vials and analysed by LC-
MS/MS and LC-HRMS. All samples and QCs were extracted and analysed in 
duplicate.   
4.2.2.3 Identification and quantification of BCM5 and BCM7 by liquid 
chromatography-tandem mass spectrometry  
a. Calibration standards 
Mixed standard solutions of BCM5 and BCM7 ranging from 0.1 to 1000 ng/mL (0.1, 
0.5, 1.0, 2.5, 5.0, 10.0, 25.0, 50.0, 100.0, 250.0, 500.0 and 1000.0 ng/mL) also 
containing deuterated standards BCM5-d10 and BCM7-d10 at 1000 ng/mL were 
serially diluted with ultra-pure water from the stock solutions prepared as previously 
reported  in Section 3.2.2 . Calibration standards were prepared on the day of use. 
b. Liquid chromatography-tandem mass spectrometry conditions 
Chromatographic separation of BCM5 and BCM7 was carried out as previously 
described in Section 3.2.5 with some minor modifications. BCM5 and BCM7 were 
separated using a Kinetex C18 column (Phenomenex, USA, 150 mm × 2.1 mm, 
100Å, 2.6 µm particle diameter) with a guard column (2.1 mm x 10 mm) of the same 
stationary phase. The mobile phase consisted of MeOH (A) and ultrapure water (B) 
both containing 0.1% formic acid at a flow rate of 100 µL/min. Chromatographic 
runs began with 30% (A) for 3 min, followed by a 15 min linear gradient to 95% (A). 
The mobile phase remained at 95% (A) for 10 min to elute analytes from the column. 
76 
 
 Chapter 4 
The initial conditions were re-established within 1 min and the column re-
equilibrated for 10 min before injecting the next sample. The injection volume was 
25 µL. The tuning of the electrospray ion source and the mass spectrometry 
conditions for detection of BCM5 and BCM7 were as previously described in 
Section 3.2.5. 
4.2.2.4 Identification and quantification of BCM5 and BCM7 by liquid 
chromatography-high resolution mass spectrometry 
a. Calibration standards 
Serial concentrations of calibration standards were prepared as described in Section 
4.2.2.3a   
b. Liquid chromatography-high resolution mass spectrometry conditions 
Separation and identification of BCM5 and BCM7 in milk extracts by LC-HRMS 
were carried out using an Accela 600 LC system coupled to a high resolution mass 
spectrometer (LTQ Orbitrap XL, Thermo Fisher Scientific Corporation, Waltham, 
USA) fitted with an electrospray ion source operated in positive ionisation mode 
(+eV). BCM5 and BCM7 were chromatographically separated as described in 
Section 4.2.2.3b. To minimise potential carryover, the needle of the injector was 
rinsed thoroughly within the injection port with MeOH before and after each 
injection. ESI and HRMSn settings are reported in Table 10. 
Full calibration of the LTQ Orbitrap XL in the 150-2000 m/z range was conducted 
weekly with the positive ion calibration solution provided by Thermo Scientific. 
Optical lenses were optimised with a standard solution of BCM5 and BCM7 prior 
each measurement. For increased mass accuracy on the LTQ Orbitrap XL, a 
plasticiser interfering peak present in the LC mobile phase at m/z 214.0887 (n-butyl 
benzenesulfonamide, C6H5SO2NH(CH2)3CH3, [M+H]+=214.0896 m/z), was used for 
the lock mass function. For screening and quantification, two different MS 
acquisition modes were combined in the same analytical run. The screening analysis 
was conducted operating the LTQ Orbitrap XL mass spectrometer in full-scan mode 
from 70-1000 m/z with a mass resolution of 60.000 (@ 400 m/z). In addition, all of 
the target analytes and deuterated standards were specifically analysed for 
quantitation in single reaction monitoring (SRM) mode using the LTQ ion trap mass 
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spectrometer. The following SRM transitions and collision induced dissociation 
(CID) energies were used: BCM5 (580.3408.3 m/z; CID=25); BCM5-d10 
(590.3418.3 m/z; CID=25); BCM7 (790.4383.2 m/z; CID=23); BCM7-d10 
(800.4383.2 m/z; CID=23). The presence of the detected peptides was confirmed 
in the sample extracts by operating the LTQ Orbitrap XL in HRMS2 mode, where the 
mass spectrometer is forced to isolate the parent compound, fragment it in the LTQ 
ion trap and then scan for the product ions in the Orbitrap mass analyser. A mass 
resolution of 30000 (@ 400 m/z) was used for the fragmentation experiments. Along 
with the chromatographic retention time, for BCM5 and BCM7 identification the 
deviation of the measured mass (i.e. parent compound and fragments) was compared 
against the theoretical mass (< 5ppm, relative error) and, fragmentation pattern of 
BCM5 and BCM7 in the samples was compared with that obtained from analysis of 
standard solutions. Data was processed using Xcalibur QualBrowser 2.0.7 SP1, 
TraceFinder 3.1 and MassFrontier 7.0. 
Table 10. Summary of ESI and HRMSn parameters used for target analysis of BCM5 
and BCM7 in milk extracts 
Parameter Setting 
Spray voltage (kV)  4.0 
Capillary voltage (V) -35 
Capillary temperature (°C) 275 
Sheath gas flow rate (Arb) 20 
Aux gas flow rate (Arb) 0 
Sweep gas flow rate (Arb) 0 
Tube Lens (V) -110 
Scan range (m/z) 70-1000 
Ion trap full MS automatic gain control  target 3E4 
Ion trap MSn automatic gain control target 1E4 
Fourier transform full MS automatic gain control target 2E5 
Fourier transform MSn automatic gain control target 1E5 
Ion trap and fourier transform  micro scans 3 
Ion trap  full MS Max ion time (ms) 10 
Fourier transform  MSn Max ion time (ms) 200 
MS2 isolation window (m/z) 1 
 Arb: arbitrary units; ms: milliseconds 
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4.3 Results  
4.3.1 Content of beta-casomorphin 5 and beta-casomorphin 7 in pasteurised milk 
and skim milk powder 
4.3.1.1 Analysis of sample extracts by liquid chromatography-tandem  mass 
spectrometry 
SPE is a useful technique used widely in quantitative analysis. Preparation of 
samples by SPE followed by LC-MS/MS analysis can reduce interferences causing 
ion suppression overall improving LODs. However, added analysis time and costs 
are associated with SPE use. Thus, before a real quantification of the peptides in 
various pasteurised milk and skim milk powder samples by both LC-MS/MS and 
LC-HRMS, a preliminary work was conducted. In this regard, a sample of 
commercial UHT milk and reconstituted milk were prepared as described in Section 
3.2.4 and then analysis by LC-MS/MS. In the preliminary samples of commercial 
UHT and reconstituted milk, LC-MS/MS chromatograms detected BCM7 but not 
BCM5 (Figure not shown), however chromatogram peaks of BCM7 were relatively 
poor. Therefore, in order to improve LODs, SPE was used for extraction and 
purification of peptides instead of 0.45 µm membrane filters before injection into the 
LC-MS/MS and LC-HRMS systems. 
Figure 8 shows that peaks of BCM7 and BCM7-d10 are unequivocally detected in 
seven samples of pasteurised milk (PM 1, PM 2, PM 3, PM 4, PM 5, PM 6 and PM 
7) and the reconstituted milk. The levels of BCM7 were between 0.25 ng/g and 2.16 
ng/g, whereas BCM5 was below LOD in all samples of pasteurised milk (Table 11). 
This result for BCM5 agrees with those of De Noni and Cattaneo (2010) and Juan-
García et al. (2009). 
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Figure 8. LC-MS/MS chromatograms of BCM7 and its deuterated standard (BCM7-
d10) in different milk extracts 
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Table 11. BCM5 and BCM7 levels in dairy products analysed by LC-MS/MS 
Milk products 
BCM7 level 
(ng/g)a 
BCM5 level 
(ng/g) 
Milk   
PM 1 0.44±0.01 < LOD 
PM 2 0.40±0.01 < LOD 
PM 3 0.53±0.01 < LOD 
PM 4 0.40±0.00 < LOD 
PM 5 2.16±0.05 < LOD 
PM 6 0.32±0.01 < LOD 
PM 7 0.25±0.01 < LOD 
Skim milk powder   
SMP 0.34±0.00b < LOD 
QCs 108.6±1.7c 97.4±0.4c 
a average levels (n=2) ± standard deviation 
b BCM7 level in reconstituted milk from skim milk powder 
c average recovery (n=2) ± standard deviation 
PM: Pasteurised milk 
SMP: Skim milk powder 
LOD: Limit of detection 
QCs: Quality control samples 
4.3.1.2 Analysis of sample extracts by liquid chromatography-high resolution mass 
spectrometry 
In this experiment, three pasteurised milks (PM 3, PM 5 and PM 6) previously 
analysed by LC-MS/MS were selected based on their characteristic high, medium 
and low content of BCM7 (Table 11) and re-analysed by LC-HRMS. In addition, 
seven further samples of pasteurised milk (PM 8, PM9, PM10, PM11, PM12, PM13 
and PM 14) purchased from various supermarkets in Australia (Table 9) were 
analysed by LC-HRMS.  
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Figure 9. LS-HRMS chromatograms of BCM7 and its deuterated standard (BCM7-
d10) in different milk extracts 
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Figure 9 shows that the LC-HRMS chromatographic peaks of BCM7 and its 
deuterated standard are detected in six samples of pasteurised milk including three 
products previously analysed by LC-MS/MS, namely PM 3, PM 5, PM 6, PM 10, 
PM 11 and PM 12. Furthermore, the high resolution mass spectrometry data with a 
mass accuracy relative error below 5 ppm unequivocally confirmed the presence of 
this peptide in these six samples of milk (Table 12). The content of BCM7 in PM 3, 
PM 5 and PM 6 showed in Table 12 also compares well to the levels reported by 
analysis using LC-MS/MS (Table 11). The content of BCM7 in PM 8, PM 9, PM 13 
and PM 14 (Figure not shown) was below LOD (Table 12). BCM5 was below LOD 
in all samples of pasteurised milk.  
Table 12. Mass and level of BCM7 identified in different samples of pasteurised 
milk by LC-HRMS.  
Products 
[M+H]+teo 
(Da) 
[M+H]+exp 
(Da) 
Relative error 
(ppm) 
BCM7 levela  
(ng/g) 
PM 3  790.4134 790.4123 1.4 0.50±0.04 
PM 5  790.4134 790.4122 1.4 2.38±0.09 
PM 6 790.4134 790.4116 2.3 0.41±0.01 
PM 8 790.4134 n.d n.a <LOD 
PM 9 790.4134 n.d n.a <LOD 
PM 10 790.4134 790.4111 2.9 0.13±0.01 
PM 11 790.4134 790.4103 3.8 0.39±0.01 
PM 12 790.4134 790.4122 1.4 0.38±0.01 
PM 13 790.4134 n.d n.a <LOD 
PM 14  790.4134 n.d n.a <LOD 
QCs 790.4134 790.4120 1.7 102.4±0.1b 
                         a Average values of two analysis (n=2) ± standard deviation 
                        b Average recoveries (n=2) ± standard deviation 
               [M+H]+exp: Experimental molecular ion mass; [M+H]+teo: Theoretical molecular ion mass 
                PM: Pasteurised milk 
                n.d: Not detected 
                n.a: Not available 
               QCs: Quality control samples 
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4.3.2 Content of beta-casomorphin 5 and beta-casomorphin 7 in commercial 
yoghurts 
LC-MS/MS chromatograms showed that BCM5 and BCM7 were not detected peaks 
in the commercial yoghurts (Figure not shown). This result agrees with the findings 
of De Noni and Cattaneo (2010). As discussed in Chapter 3, using SPE for cleaning-
up of yoghurt supernatants before analysis by LC-MS/MS can improve LODs. 
However, LC-MS/MS analysis showed that all samples of yoghurt seemed not to 
contain BCM5 and BCM7 (<LOD) in this investigation. Thus, none of the yoghurt 
samples in the present study were subjected to clean-up by SPE before analysis by 
LC-MS/MS. The absence of BCM5 and BCM7 in the commercial yoghurts may 
have been due to degradation of these peptides, which possibly were originally 
present in the milk, during yoghurt manufacture and storage. Investigation of this 
potential phenomenon will be reported in Chapter 5 and 6.             
4.4 Discussion 
4.4.1 Occurrence of beta-casomorphin 5 and beta-casomorphin 7 in pasteurised milk 
and reconstituted skim milk powder 
Milk extracts of UHT milk and reconstituted milk were prepared by using 0.45 µm 
membranes for cleaning-up supernatant and then analysed by LC-MS/MS. LC-
MS/MS chromatograms showed that BCM7 was detected in these two samples of 
milk; however, the S/N of the peaks corresponding to BCM7 were generally low 
resulting in “noise” chromatographic traces. Milk is a complex food matrix in which 
proteins, fat, lactose or pre-existing peptides can cause interference during 
determination of BCM5 and BCM7 by chromatographic and mass spectrometric 
methods. In order to improve the S/N of the peaks and corresponding LODs of 
BCMs (Chapter 3), SPE was used for extraction and cleaned-up of supernatants 
before injecting into the LC-MS/MS system. After SPE extraction and clean-up, 
LODs resulted 0.4 ng/g and 0.2 ng/g for BCM5 and BCM7, respectively which were 
lower than those achieved by direct injection of supernatant (Chapter 3). The LC-
MS/MS chromatograms show that peaks of BCM7 and its deuterated homologue 
(BCM7-d10) were found in all samples of pasteurised milk and reconstituted milk 
(Fig. 8). The levels of BCM7 are given in Table 11. 
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Although low resolution LC-MS/MS is a highly sensitive and selective analytical 
technique currently used worldwide for the quantitative assessment of polar/apolar 
organic compounds, it lacks the capability of providing information regarding the 
accurate mass of parent compounds and fragments. The results obtained as using LC-
HRMS show that LODs were 0.25 ng/g and 0.1 ng/g for BCM5 and BCM7, 
respectively. LC-HRMS data showed that BCM7 presents in a range of various 
pasteurised milks and skim milk powder at different levels (Table 12).  
Enzyme and acid action are key factors in the hydrolysis of β-CNs to peptides in 
milk and dairy products (Meltretter et al., 2008). In addition, heat treatment also 
plays an important role in the breakdown of proteins to peptides (Meltretter et al., 
2008). Heat treatment of milk is commonly carried out at either 72 – 75 °C for 15 s 
(high temperature-short time; HTST) or at 125 – 138 °C for 2 s (ultra-pasteurisation) 
in production of pasteurised milk and at extra low heat (<70 °C) or low heat (70 °C 
for 15 s) before the evaporation and spay drying processes used in skim milk powder 
manufacture (Gosta, 1995). Under these heat treatment regimes, the degradation of 
β-CNs to BCM7 by acid-induced hydrolysis is very unlikely since little change in pH 
of the milk (6.5-6.7) occurs. Meltretter et al. (2008) used MALDI-TOF-MS to 
identify five new peptides, not present in raw milk, after heating at 72, 85 and 120 °C 
for 10, 20 and 30 min respectively; however none of these peptides was reported as 
BCM7. Furthermore, these authors did not report any m/z matching with that of 
BCM7 in commercially pasteurised, ultra-pasteurised or UHT milk. Similarly, using 
LC-MS/MS, Gaucher et al. (2008) did identify pro-BCMs such as β-CNf(54-68), β-
CNf(54-69), β-CNf(55-66), β-CNf(55-68) and β-CNf(57-68) but no BCM7 in UHT 
milk.  De Noni and Cattaneo (2010) did not detect BCM5 and BCM7 in unprocessed 
milk, commercial pasteurised, sterilised UHT milk and skim milk powder used LC-
MS/MS. Therefore, BCM7 found in some samples of pasteurised milk in this 
research may be due to its pre-existence in raw milk, possibly released by 
endogenous or exogenous enzyme action, rather than to formation during the 
pasteurisation process. 
The content of BCM7 varies in samples of pasteurised milk (Tables 11 and 12). As 
indicated in Table 9, samples of pasteurised milk were produced by different dairy 
companies around Australia, as a result raw milk was very likely to have been 
supplied from different dairy herds. Therefore, the differences in the concentrations 
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of BCM7 observed are probably related to differences in the genetic make-up of each 
herd (e.g. different breeds). The present study showed that three samples of 
pasteurised milk, namely PM 7, PM 13 and PM 14, did not contain BCM7 or only 
contained it at a low concentration (Tables 11 and 12). According to manufacturers, 
these three samples of pasteurised milk contained β-CN A2 variant at 10 mg/mL 
(Table 9). Fox and McSweeney (1998) indicated that there is about 9.8 mg/mL of β-
CN in bovine milk. As a result, the samples PM 7, PM 13 and PM 14 in the present 
work may only contain the β-CN A2 variant. This finding indicates that BCM7 may 
not be generated from β-CN A2 variant or only formed at a very low concentration. 
These results agree with that reported by Korhonen and Marnila (2013). The results 
also showed that two other samples of pasteurised milk (PM 8 and PM 9) were not 
detected BCM7 (Table 12), suggesting that these samples of milk probably contain 
only the β-CN A2 variant. Therefore, the raw milk supplied for production of PM 8, 
PM 9, PM 13 and PM 14 may have been mainly collected from herds of A2/A2 
cows. 
Seven of the milk samples (PM 1, PM 2, PM 3, PM 4, PM 6, PM 11 and PM 12) 
containing BCM7 (Tables 11 and 12) were not claimed by their manufacturers to 
contain specific β-CN variants with the exception of PM 11 that was claimed to 
contain both β-CN A2 and β-CN A1 variant (Table 9). Consequently, the raw milk 
used for production of this milk is likely to have been collected from herds of A1/A2 
cows. In the present work, one sample, PM 5 had BCM7 at the highest concentration 
(Table 12) and thus, may have been collected from herds with a greater 
predominance of A1/A1 cows.   
There is currently a DNA test for identification of A2/A2 cows available in Australia 
and New Zealand, but it is not used widely for dairy farmers or industry. Several 
milk manufacturers in Australia have applied this test to segregate individual cows 
into A2/A2, A1/A2 and A1/A1 herds. Therefore, milk collected from these 
segregated herds could contain different ratios of β-CN A2 to β-CN A1 variant, 
leading to the difference in content of BCM7 in different samples of pasteurised 
milk.  
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4.4.2 .Occurrence of beta-casomorphin 5 and beta-casomorphin 7 in commercial 
yoghurts. 
The release of BCM7 during in vitro digestion of the β-CN A1 variant (De Noni, 
2008; Haq et al., 2015; Jinsmaa & Yoshikawa, 1999) and during in vivo digestion of 
milk protein (Boutrou et al., 2013) has been reported. In addition, a number of 
studies have reported the finding of BCM7 and other related BCMs in some varieties 
of cheese (De Noni & Cattaneo, 2010; Jarmolowska et al., 1999; Norris et al., 2003). 
However, the occurrence of these peptides in yoghurt is still equivocal. This is 
probably due to the lack of sensitivity of analytical methods previously used for 
analysis of BCMs, and the effects of the source of raw milk, different strains of 
yoghurt culture, and days of storage on the formation and degradation of these 
peptides. The present experiment focused on identification and quantification of 
BCM5 and BCM7 in various yoghurts produced by different dairy manufacturers 
from Australian milk (Table 9) by LC-MS/MS.   
As presented in Chapter 3, LC-MS/MS using BCM5-d10 and BCM7-d10 as internal 
standards was successfully developed for identification and quantification of BCM5 
and BCM7 at very low levels (sub-ng/g) in yoghurt. This method was applied to ten 
commercial cow milk yoghurts, fermented with varieties strains of culture at various 
days of storage (Table 9). Both  BCM5 and BCM7 were lower than LOD (see 
Chapter 3) in all yoghurts, indicating that either these peptides were (a) never formed 
or present in yoghurts or in the milk used for their manufacture or (b) were formed or 
present at some stage but were degraded during yoghurt fermentation and storage. 
Investigations on these hypotheses will be reported in Chapters 5 and 6.   
4.5 Conclusions 
Application of LC-MS/MS and LC-HRMS using BCM5-d10 and BCM7-d10 as 
internal standards successfully simultaneously identified and quantified BCM5 and 
BCM7 in commercial milk products: yoghurt, pasteurised milk and skim milk 
powder. Furthermore, purification of extracts using SPE before injecting to LC-
MS/MS and LC-HRMS system is a useful technique for improvement of LOD. This 
is the first study on investigation of BCM5 and BCM7 in a large number of various 
milk products made from Australian milk. The concentration of BCM7 at different 
levels in a range of pasteurised milk and skim milk powder indicates that the raw 
milk may be collected from herds varying in their composition of A2/A2, A1/A1 or 
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A1/A2 genotypes. The presence of BCM7 in pasteurised milk and skim milk powder 
may provide evidence that BCM7 may be degraded by bacteria derived enzymes 
during yoghurt process and thus, the hydrolysis of BCM7 during fermentation and 
storage of yoghurt will be studied further in Chapter 5. This finding provides new 
knowledge for further studies concerning A2/A2, A1/A1 or A1/A2 genotypes and 
BCM7; and the potential bioactivity of BCM7 as intake of milk. In addition, the 
impact of heat treatments to these milk containing pure β-CN variants on their 
concentrations of BCM7 should be further investigated. 
4.6 Papers 
Part of this study has been published in the following journal article: D.D. Nguyen, 
F. Busetti, S.K. Johnson and V.A. Solah (2015). Identification and quantification of 
native beta-casomorphins in Australian milk by LC-MS/MS and LCHRMS. Journal 
of Food Composition and Analysis, 44, 102-110. 
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CHAPTER 5 EFFECT OF FERMENTATION AND STORAGE DURING 
YOGHURT PROCESSING ON DEGRADATION OF BETA-
CASOMORPHINS 
5.1 Introduction 
In recent years, fermented milk and yoghurt products containing peptides with 
biological activity such as ACE-I and antioxidant action have been widely studied 
(Donkor et al., 2007; Otte et al., 2011; Sabeena Farvin et al., 2010).  These peptides 
are mainly released from milk proteins by bacteria during fermentation and storage 
processes (Nielsen et al., 2009).  
Yoghurt is commonly fermented with L. delbrueckii ssp. bulgaricus and S. 
thermophilus at 42-45 °C until the pH drops to 4.3-4.5 (Paul & Somkuti, 2009). 
During fermentation of milk, caseins are hydrolysed into large peptides by the cell 
wall-associated proteinases of bacteria. Subsequently, these large peptides are 
transported into the bacterial cells and hydrolysed into a large number of shorter 
peptides, including peptides with opioid activity (Sabeena Farvin et al., 2010), by 
intracellular peptidases (Nielsen et al., 2009). During cold storage, peptides with 
bioactive property are also produced (Donkor et al., 2007; Papadimitriou et al., 
2007), but some other peptides are hydrolysed (Gobbetti, Ferranti, Smacchi, 
Goffredi, & Addeo, 2000). BCMs are proline-rich peptides (Table 1). Proline-
containing peptide bonds are known to be resistant to hydrolysis by digestive 
enzymes, but are unstable with PepX activity produced from most dairy cultures 
(Donkor et al., 2007). Interesting data is becoming available on transport of 
peptide(s) across gut wall. Osborne et al. (2014) showed that BCM-7 was hydrolyzed 
by cell surface peptidases of caco-2 cells. However, the degradation of BCM5 and 
BCM7 during fermentation of milk and subsequent storage of yoghurt has received 
little attention in the scientific literature.  
In the present project, the measurement of BCM5 and BCM7 in commercial yoghurts 
fermented a mixture of L. delbrueckii ssp. bulgaricus and S. thermophilus, and other 
LAB were carried out as detailed in Chapter 4 and none of the investigated yoghurts 
contained BCM5 and BCM7. Similarly, De Noni and Cattaneo (2010) did not detect 
BCM5 and BCM7 in commercial yoghurts that had been stored for 30 days before 
analysis using LC-MS/MS. In contrast, BCM7 has been reported to present in 
commercial yoghurts and its level was observed to decrease during storage using 
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ELISA (Jarmolowska, 2012). However, from these studies, it remains unclear if 
BCM7 is released during fermentation, and if, in turn, it is degraded during storage.    
The aim of study described in this chapter was to (a) investigate the degradation of 
BCM5 and BCM7 analysed by LC-MS/MS in yoghurt during fermentation of 
reconstituted milk with L. delbrueckii ssp. bulgaricus and S. thermophilus and (b) 
determine the effect of storage of the yoghurt fermented to different pH values on the 
level of BCM5 and BCM7.  
5.2 Materials and methods 
5.2.1 Materials and chemicals 
Skim milk powder, produced in Rakaia, New Zealand, was supplied by A2 Dairy 
Products Australia Pty Ltd (Botany, NSW, Australia). Other materials and chemicals 
used for the determination of BCM5 and BCM7 in this study have been previously 
described in Section 3.2.1. Gly-pro-pNA triflouroacetate salt was purchased from 
Auspep Pty. Ltd. (Tullamarine, VIC, Australia). 4-nitroaniline (pNA) was a product 
of Sigma-Aldrich (China). 
5.2.2 Methods 
5.2.2.1 Production of yoghurt 
Yoghurt made from the skim milk powder was prepared by the processes illustrated 
in Fig. 10. Reconstituted milk was firstly prepared by dissolving the skim milk 
powder in deionised water (1.3/10; w/v) and thoroughly mixed by a stirrer. The water 
had been boiled for 10 min and then cooled to 55 °C before use. The reconstituted 
milk was inoculated with 0.003% (w/v) of YO-MIXTM and thoroughly mixed by 
stirring with a clean spoon. The inoculated milk was divided into 13 tubes, sealed 
and incubated at 43 °C until the pH dropped to the required values of pH 4.8 and 4.5. 
One tube was used for measurement of pH during fermentation. When the pH 
reached each of the two required values, six tubes were removed from the incubator. 
Two tubes were then extracted immediately (or stored at -20 °C prior to extraction if 
immediate extraction was not possible) and the four others were stored for one day (2 
tubes) and seven days (2 tubes) at 4 °C and then stored at -20 °C until extraction.  
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Figure 10. Production of yoghurt from skim milk powder 
5.2.2.2 Extraction of water soluble peptides 
Extraction of water soluble peptides from the yoghurt was carried out as follows: the 
yoghurt previously stored at -20 °C was thawed at room temperature for 
approximately 30 min and thoroughly mixed by inversion of tubes. Twenty five 
grams (±0.0001 g) of yoghurt was spiked with 500 ng of BCM5-d10 and 500 ng of 
BCM7-d10. In addition, a separate 25.0000 g (±0.0001 g) sample of the yoghurt was 
spiked with 500 ng of mixture of deuterated standards and 100 ng of mixture of 
BCM5 and BCM7 standard and used for QCs. The extraction was performed as 
described in Section 3.2.4. The supernatants were then filtered through Whatman 
Skim milk powder 
Mixing  
Inoculation 
Incubation 
Cold storage 
Yoghurt 
  
 - Pre-boiled at 100 °C for 10 min - Cooled down to 55 °C 
- Milk powder/water: 1.3/10, w/v 
- YO-MIX
TM 
- Culture/reconstituted milk: 0.003%, w/v  
 - 43 °C 
- pH 4.8 (6 tubes) 
- pH 4.5 (6 tubes) 
 - 4 °C 
- 1 day, pH 4.8 (2 tubes), pH 4.5 (2 tubes) 
- 7 days, pH 4.8 (2 tubes), pH 4.5 (2 tubes) 
Yoghurt stater cultures 
Deionised water 
Reconstituted milk 
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filter paper n° 541 instead of 0.45µm membrane filters. The filtrates were then 
purified using SPE cartridges (Strata-X, 500 mg/6 mL, Phenomenex, NSW, 
Australia). The SPE clean-up was carried out as described in Section 4.2.2.2. All 
samples and QCs were extracted in duplicate.   
5.2.2.3 Identification and quantification of beta-casomorphin 5 and beta-casomorphin 
7 by liquid chromatography-tandem mass spectrometry 
a. Calibration standards 
Preparation of standard solutions was carried out as described in 4.2.2.3a 
b. Liquid chromatography-tandem mass spectrometry conditions 
BCM5 and BCM7 in the yoghurt extracts were determined using the LC-MS/MS 
method described in Chapter 3 with some minor modifications of LC conditions as 
follows: Chromatographic separation ofBCM5 and BCM7 was achieved using a 
Waters XBridge C18 column (50 mm x 2.1 mm i.d., 3.5 µm particle size, 135A pore 
diameter) (Waters Tokyo, Japan) at a flow rate of 250 µL/min. An XBridge BEH 
Sentry guard cartridge (Waters) was also used to protect the analytical column. The 
mobile phase was MeOH (A) and ultrapure water (B) both containing 0.1% formic 
acid. Chromatographic runs began with 30% (A) for 3 min, followed by a 10 min 
linear gradient to 95% (A). The mobile phase remained at 95% (A) for 10 min to 
elute analytes from the column. The initial conditions were re-established within 1 
min and the column re-equilibrated for 9 min before injecting the next sample. The 
injection volume was 25 µL. The same mass spectrometry conditions were used as 
described in Chapter 3.  
5.2.2.4 Measurement of PepX activity 
a. Preparation of extract 
The extraction was performed as described by Otte et al. (2011) with some minor 
modifications. Twenty grams (±0.0001 g) of the yoghurt samples were placed in a 
centrifuge tube and then thoroughly mixed by inversion with 1 mL of 1 M sodium 
citrate. The tube was centrifuged at 15,000 × g for 20 min at 4 °C. The supernatant 
was decanted into another centrifuge tube and stored at 20 °C until analysis. Before 
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measuring PepX activity, the frozen supernatant was thawed at room temperature 
and centrifuged at 15,000 × g for 10 min at 4 °C.  
b. Measurement of PepX activity 
The PepX activity was carried out by a method adapted from Miyakawa et al. (1991). 
Gly-Pro-pNA was used as a substrate and dissolved in 0.1M NaH2PO4-NaOH pH 6.5 
at 1 mM. The substrate solution and the supernatant were separately pre-incubated at 
37 °C for 5 min. The reaction mixture consisting of 0.5 mL of Gly-Pro-pNA and 0.5 
mL of the supernatant was mixed and then incubated at 37 °C for 5 min. The reaction 
was stopped by addition of 1 mL of 30% acetic acid. The absorbance was measured 
at 410 nm using UV-1800 spectrophotometer (Shimadzu, Canby, OR, USA). Serial 
standard solutions of pNA in the range 2-200 µM was used for the calibration curve. 
The PepX activity was defined as nmole of pNA released per min per mL of yoghurt.     
5.3 Results 
5.3.1 Degradation of beta-casomorphin 5 and beta-casomorphin 7 during 
fermentation 
In the present study, the identification and quantification of BCM5 and BCM7 in the 
unfermented reconstituted milk used for manufacture of the yoghurt was performed 
in order to assist in the understanding of the release/degradation of these peptides 
during yoghurt fermentation and storage. The extraction of water soluble peptides 
was carried out as previously described in Section 4.2.2.2 and analysed by LC-
MS/MS as described in Section 5.2.2.3. Figure 11 shows chromatograms of BCM7 
and its deuterated standard BCM7-d10 in the unfermented reconstituted milk extract, 
suggesting that BCM7 presents itself in the reconstituted milk made from the skim 
milk powder. The content of BCM7 is shown in Table 13. In contrast, BCM5 was 
undetectable in the milk extract (Figure not shown). 
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Figure 11. LC-MS/MS chromatograms of BCM7 and its deuterated standard (BCM7-
d10) in the reconstituted milk 
Figure 12 shows the LC-MS/MS chromatogram of BCM7 in the yoghurt fermented 
to pH 4.8. BCM7 content was found to decrease during fermentation from pH 6.5 to 
4.8 (Table 13).  After a more prolonged fermentation for about 1 hour to pH 4.5, 
BCM7 was below LOD (Figure not shown). BCM5 was also below LOD in yoghurt 
fermented to any pH values (4.5 and 4.8) (Figure not shown).   
 
Figure 12. LC-MS/MS chromatograms of BCM7 and its deuterated standard (BCM7-
d10) in yogurt made from the reconstituted milk (pH=4.8, 0 day of storage) 
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5.3.2 Degradation of beta-casomorphin 5 and beta-casomorphin 7 during storage 
Variation in the level of BCM5 and BCM7 during storage was carried out by 
determining their level in the yoghurt at pH 4.8 and 4.5 after one and seven days of 
storage.  No detectable level of BCM5 was found in the yoghurt at any day of storage 
(Figure not shown). At end fermentation pH 4.8, BCM7 presented in yoghurt stored 
for one day (Fig. 13), but was not detected when yoghurt was stored for seven days. 
Table 13 shows that BCM7 content decreased after one day of cold storage. At the 
end of fermentation at pH 4.5, BCM7 was below LOD in yoghurt after one and seven 
days of storage (Figure not shown).  
 
 
Figure 13. LC-MS/MS chromatograms of BCM7 and its deuterated standard (BCM7-
d10) in yogurt made from the reconstituted milk (pH=4.8, one day of storage) 
5.3.3 PepX activity 
The PepX activity of the milk fermented to pH 4.8 and 4.5 and in yoghurt stored for 
various periods is showed in Figure 14. There was an increase in the PepX activity 
during fermentation, from 6.14 to 8.28 nmole pNA.min-1.mL-1as fermentation pH 
dropped from 4.8 to 4.5. For the yoghurt samples at pH 4.8, the PepX activity 
increased to 7.54 nmole pNA.min-1.mL-1 in the sample stored for one day. However, 
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after seven days of storage the PepX activity increased very slightly to 7.62 nmole 
pNA.min-1.mL-1.  
 
Figure 14.  PepX activity (nmole pNA.min-1.mL-1) in milk fermented to pH 4.8 and 
4.5 and in yoghurt stored for one and seven days 
5.4 Discussion 
Fermentation of milk in yoghurt processing causes the drop in pH to target values, 
normally 4.3-4.5, leading to changes in viscosity and texture of yoghurt, resulting in 
the desired final product characteristics (Beal, 1999). During fermentation, bacteria 
derived  proteases hydrolyse caseins into large peptide fragments, which in turn are 
degraded by peptidases into shorter peptides (Nielsen et al., 2009). Most peptides 
that contain proline residue are hydrolysed by bacteria derived PepX activity 
(Donkor, Henriksson, Vasiljevic, & Shah, 2007). BCM7 is a 3 proline-containing 
peptide (Fig. 1). The proline in second position helps BCM7 stablise with 
aminopeptidase activity produced from bacteria, however it is known to be 
hydrolysed by PepX (Hafeez et al., 2013). The present results show that BCM7 
content decreases during fermentation and completely hydrolysed as it fermented to 
pH 4.5 (Table 13). The decrease in BCM7 content correlates to the increase in the 
PepX activity during fermentation (Fig. 14), suggesting that the degradation of 
BCM7 is likely to be a result of PepX activity produced from yoghurt cultures.  
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Most dairy cultures used for fermentation of milk are LAB possessing PepX activity 
(Donkor et al., 2007). Lactococcus lactis spp. cremoris produces PepX activity 
associating to cell wall of bacterium and this enzyme has been reported to efficiently 
degrade BCM7 (Kiefer-Partsch, Bockelmann, Geis, & Teuber, 1989). Similarly, 
Matar and Goulet (1996) have demonstrated that a strain of L. helveticus completely 
hydrolysed BCM7, whereas a mutant strain of L. helveticus that does not possess 
PepX only partly hydrolysed BCM7 to BCM4. Interestingly, L. delbrueckii 
ssp.bulgaricus and S. thermophilus has also been reported to be capable of producing 
extracellular PepX (Hafeez et al., 2013; Meyer & Jordi, 1987).  
In yoghurt processing, L. delbrueckii ssp. bulgaricus and S. thermophilus rapidly 
symbiotically grew during fermentation. It has been documented that lysis is minimal 
and cell numbers increase during fermentation (Beal, 1999; Donkor et al., 2007). In 
the present work, the fermented milk samples were centrifuged at 15,000 × g for 20 
min, leading to the absence of bacteria cells in the extracts.  Therefore, PepX activity 
measured in the extract at fermentation pH 4.8 and 4.5 is extracellular enzyme. The 
increase in PepX activity during fermentation could be due to more bacteria cells that 
could release more extracellular PepX. 
S. thermophilus is an important bacterium in first stage of fermentation of milk into 
yoghurt. In addition to the production of  pyruvic acid, formic acid, folic acid, fatty 
acids and CO2 for the growth of L. delbrueckii ssp. bulgaricus (Settachaimongkon et 
al., 2014), S. thermophilus strains also produce peptides with ACE-I property during 
fermentation (Miclo et al., 2011). However, Hafeez et al. (2013) have reported that 
strains of S. thermophilus completely degraded BCM7 after a 4-6 hour incubation. 
These periods of incubation are similar to those in the present study; 4.5 and 5.5 
hours for fermentation to pH 4.8 and 4.5, respectively (Table 13). However, the in 
vitro medium in the study of Hafeez et al. (2013) is different from that in yoghurt. In 
contrast to S. thermophilus, the degradation of BCM7 by L. delbrueckii ssp. 
bulgaricus in an in vitro study has not been reported. In yoghurt processing, the role 
of each bacterium in degradation of BCM7 has received very little attention in 
scientific literature. Therefore, studies on the capacity of each bacterium for 
hydrolysis of BCM5 and BCM7 during yoghurt processing will be described in 
Chapter 6.     
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Table 13. BCM5 and BCM7 content of reconstitute milk and yoghurt fermented to 
different pHs  
Samples Fermentation time 
(h) 
BCM7 
ng/g 
BCM5 
ng/g 
Reconstituted milk pH 6.5 0 1.4a ± 0.00  <LOD 
Reconstituted milk fermented to pH 4.8 4.5 0.29a ± 0.01  <LOD 
Reconstituted milk fermented to pH 4.5 5.5 <LOD <LOD 
QCs (reconstituted milk samples)  102b ± 1 103b ± 1 
a Mean values, ng/g (n = 2) 
b Recovery (%) is the average ±%RSD of reconstituted milk samples (n=2) spiked with 100 ng/g of 
BCM5 or BCM7 .  
QCs: Quality control sample 
LOD: Limit of detection 
The formation/degradation of peptides in yoghurt depends on the period of storage. 
Some peptides may be degraded and others are formed during prolonged storage 
(Donkor et al., 2007). The present study shows that cold storage has influence on the 
stability of BCM7. This peptide was degraded in yoghurt samples at pH 4.8 stored 
for one day and completely hydrolysed after seven days of storage (Table 14). The 
results also show that PepX activity increases after one day of storage (Fig. 14), 
suggesting that PepX activity is likely a factor causing decrease in BCM7 content 
during storage. The increase in PepX activity in yoghurt samples at pH 4.8 may be 
due to growth of L. delbrueckii ssp. bulgaricus and S. thermophilus during cold 
storage (Donkor et al., 2007).   
The present work also shows that neither BCM5 nor BCM7 was found in yoghurt at 
pH 4.5 stored for any storage period. This finding agrees with De Noni and Cattaneo 
(2010) who measured BCM5 and BCM7 in commercial yoghurts. Similarly, 
Schieber and Brückner (2000) have identified some pro-BCMs in yoghurt fermented 
with L. delbrueckii ssp. bulgaricus and S. thermophilus and stored for 21 days, but 
neither BCM5 nor BCM7 was identified. However, Jarmolowska (2012) found 
BCM7 in commercial yoghurt and observed that the content of this peptide decreased 
during storage.  
128 
 
 Chapter 5 
As can be seen in Fig. 1, BCM7 is a parent peptide of BCM5, so it can be a 
hypothesised that BCM7 is hydrolysed into BCM5 by peptidases during fermentation 
and storage of yoghurt. However, Hafeez et al. (2013) clearly show the release of X-
Pro dipeptides from N-terminal side to BCM7 and not the C-terminal side. 
Moreover, chromatograms from the present study do not show any peak of BCM5 
(Figure not shown), indicating that this peptide was not released from hydrolysis of 
BCM7. Two di-peptides described as β-CNf60-61 and β-CNf62-63 have previously 
been identified in commercial yoghurts (Kunda et al., 2012). Furthermore, Hafeez et 
al. (2013) have reported that BCM7 is cleaved at peptide bonds Pro61-Phe62 and 
Pro63-Gly64 (see Fig. 1) to form β-CNf60-61, β-CNf62-63, β-CNf64-66 and β-
CNf62-66 when BCM7 was incubated with strains of S. thermophilus for 22 hours at 
42 °C. However, BCM5 is found in some cheese produced by fermentation of milk 
with other LAB (Sienkiewicz-Szłapka et al., 2009). This indicates that the formation 
of BCM5 may depend on strain of bacteria used in dairy processing (Jarmolowska, 
2012).    
Table 14. BCM5 and BCM7 content in yoghurt made from reconstituted milk after 
different storage days 
Cold storage (day) 
BCM7 (ng/g) BCM5 (ng/g) 
pH 4.8 pH 4.5 pH 4.8 pH 4.5 
1 0.17a ± 0.01 <LOD <LOD <LOD 
7 <LOD <LOD <LOD <LOD 
QCs (yoghurt samples) 104b ± 1.0 104b ± 2.0 
a Mean values, ng/g (n = 2) 
b Recovery (%) is the average ±%RSD of yoghurt samples (n=2) spiked with 100 ng/g of BCM5 or 
BCM7 .  
QCs: Quality control sample 
LOD: Limit of detection 
5.5 Conclusions 
This study demonstrated that fermentation and storage in yoghurt processing have a 
strong influence on the degradation of BCM7. The content of BCM7 decreases 
during fermentation and completely hydrolysed as fermentation of milk to pH 4.5. 
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BCM7 in yoghurt produced by fermentation of milk to pH 4.8 decreased during cold 
storage and completely degraded after seven days of storage. The results also show 
that yoghurt produced by fermentation of milk to pH 4.5, which is a characteristic of 
final yoghurt, does not contain BCM7, with regard to various periods of storage. The 
degradation of BCM7 is likely a result of bacteria derived PepX. The content of 
BCM5 and BCM7 found in milk were zero and very low, respectively, leading to a 
hard determination of the remaining of their content as fermentation of milk to pH 
4.5. Addition of standard BCM5 and BCM7 to milk for investigation of their 
remaining as milk fermented to pH 4.5 and during cold storage will be reported in 
Chapter 6.  
5.6 Papers 
The results of this study were presented at the 2nd International Dairy Federal 
Symposium on Microstructure of Dairy Products and 5th International Dairy Federal 
Symposium on Science and Technology of Fermented Milk on 3-7 March 2014 in 
Melbourne, Australia (Appendix 1). 
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CHAPTER 6 DEGRADATION OF BETA CASOMORPHINS BY L. delbruekii spp. 
bulgaricus and S. thermophilus DURING YOGHURT MANUFACTURE 
6.1 Introduction 
L. delbruekii spp. bulgaricus and S. thermophilus are two LAB widely used as a 
starter culture for co-fermentation of milk in yoghurt manufacture (Tamime & 
Robinson, 1999). L. delbruekii spp. bulgaricus produces peptides and essential 
amino acids that stimulate the growth of S. thermophilus (Courtin et al., 2002; 
Shihata & Shah, 2000). In turn, S. thermophilus produces pyruvic acid, formic acid, 
folic acid, fatty acids and CO2 for L. delbruekii spp. bulgaricus (Settachaimongkon et 
al., 2014). Therefore, co-cultivation results in the rapid growth of these bacteria in 
the milk and hence, rapid acidification (Courtin et al., 2002). Co-fermentation of 
milk by these bacteria during manufacture of yoghurt also produces various bioactive 
peptides such as ACE-I peptides (Donkor et al., 2007; Kunda et al., 2012; 
Papadimitriou et al., 2007), antioxidant peptides (Sabeena Farvin et al., 2010), 
antimicrobial peptides (Poyrazoglu Coban et al., 2012) and opioid peptides 
(Jarmolowska, 2012).  
In addition to L. delbruekii spp. bulgaricus and S. thermophilus, yoghurt can also be 
fermented with other LAB such as L. acidophilus, L. casei, Bifidobacterium or L. 
paracasei spp. paracasei (Donkor et al., 2007; Papadimitriou et al., 2007; Shihata & 
Shah, 2002). The previous study in this research project (Chapter 4) showed that 
none of the commercial yoghurts fermented with various cultures contained BCM5 
or BCM7. In chapter 5 of this thesis it was reported that BCM7 was degraded during 
fermentation of milk from pH 6.5 to pH 4.8 and then to 4.5 using a mixture of L. 
delbruekii spp. bulgaricus and S. thermophilus.  In addition, this peptide is also 
completely degraded when the pH 4.8 yoghurt was stored for seven days (Chapter 5). 
This degradation may be the reason why BCM5 and BCM7 was not present in the 
commercial yoghurts analysed in chapter 4. Similarly, Jarmolowska (2012) observed 
that there is a decrease in content of BCM7 in commercial yoghurt containing L. 
delbruekii spp. bulgaricus and S. thermophilus during storage, but BCM7 was still 
found in yoghurt stored for 18 days.  However, the role of individual bacterial strain 
in the degradation of BCM7 in yoghurt has received little attention in the scientific 
literature. 
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L. delbruekii spp. bulgaricus and S. thermophilus can be used individually for 
fermentation of milk. Both bacteria have been demonstrated to be capable of 
hydrolysing antimicrobial and antihypertensive peptides to varying extents (Paul & 
Somkuti, 2009; Somkuti & Paul, 2010). Interestingly, S. thermophilus possess PepX 
that hydrolyses BCM7 to smaller peptides in an in vitro study (Hafeez et al., 2013). 
There is little research reporting on the degradation of BCM7 by S. thermophilus or 
L. delbruekii spp. bulgaricus during yoghurt manufacture at pH 4.5. Also, research 
on the degradation of BCM5 by these bacteria has not been reported.  
The aim of this study was to investigate the influence of S. thermophilus and L. 
delbruekii spp. bulgarius individually on the degradation of BCM5 and BCM7 when 
milk fermentation to pH 4.5, which is characteristic of final yoghurt, and during its 
cold storage. To conduct this study, standards of BCM5 and BCM7 were spiked into 
milk and their concentration measured during yoghurt production.   
6.2 Materials and Methods 
6.2.1 Materials and chemicals 
UHT milk was purchased in November 2014 from a supermarket in Perth, Western 
Australia. Yoghurt cultures (LB 340 LYO and CHOOZITTM TA 52 LYO, Danisco, 
France) were obtained as freeze-dried powders. LB 340 LYO contains L. delbrueckii 
spp. bulgraricus and CHOOZITTM TA 52 LYO contains S. thermophilus. Other 
materials and chemicals used in this study have been previously described in Section 
3.2.1. 
6.2.2 Methods 
6.2.2.1 Production of yoghurt 
The yoghurt manufacturing process is illustrated in Fig. 15. UHT milk was warmed 
in an incubator until it reached 43 °C. The warmed milk was added the mixture of 
standard BCM5 and BCM7 at 40 ng/g (1,000 ng/25 g of yoghurt) and separate 
batches of milk were inoculated with either 0.06% (w/w) of S. thermophilus, 0.06% 
(w/w) of L. delbrueckii spp. bulgraricus or 0.06% (w/w) of mixture of L. delbrueckii 
spp. bulgraricus and S. thermophilus (50/50, w/w).  The inoculated milk was divided 
into seven sterilised tubes, sealed and fermented at 43 °C until the pH dropped to 4.5. 
One tube was used for measurement of pH during fermentation. When the pH 
reached the required value, two tubes were extracted immediately (or stored at -20 °C 
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to preserve the sample until extraction) and two tubes each were stored for one and 
seven days at 4 °C and then preserved at -20 °C until extraction. In addition, six tubes 
of UHT milk spiked the mixture of standard BCM5 and BCM7 at 40 ng/g were 
acidified with 1 M HCl until pH 4.5 and stored for 0, 1 and 7 days as described for 
the fermented samples. The acidified milk was used for investigation of effect of pH 
on the stability of BCMs independent of any effect due to the bacterial fermentation. 
 
Figure 15. Production of yoghurt from the UHT milk spiked with standard BCM5 
and BCM7 
6.2.2.2 Extract of water soluble peptides 
The extraction was performed in duplicate (n=2) as described in Section 5.2.2.2.  
UHT milk 
Warming up   
Inoculation 
Incubation 
Cold storage 
Yoghurt 
  
- LB 340 LYO 
- CHOOZITTM TA 52 LYO 
- CHOOZITTM TA 52 LYO and LB 340 LYO (50/50)  
- Culture/ milk: 0.06%, w/w 
  
 - 43 °C 
- pH 4.5  
 - 4 °C 
- 1 day 
- 7 days 
Yoghurt stater cultures 
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6.2.2.3 Determination of beta-casomorphin 5 and beta-casomorphin 7 by liquid 
chromatography-high resolution mass spectrometry 
Identification and quantification of BCM5 and BCM7 by LC-HRMS were conducted 
as described in Section 4.2.2.4. 
6.3 Results 
6.3.1 Degradation of beta-casomorphin 5 by L. delbrueckii spp. bulgraricus and S. 
thermophilus 
In order to investigate the stability of BCM5 in the presence of individual bacterial 
strains used in yoghurt processing, BCM5 was spiked into the milk and then the milk 
fermented to pH 4.5 with either S. thermophilus or L. delbrueckii spp. bulgraricus or 
a mixture of the two and subsequently stored for 0, 1 and 7 days at 4 °C. In 
comparison, the integrity of BCM5 due to pH alone was investigated by acidification 
of the BCM5 spiked milk with 1M HCl to pH 4.5 prior to the storage protocol. 
 
Figure 16. LC-HRMS chromatogram of BCM5 and BCM7 in UHT milk spiked with 
BCM5 and BCM7 standard and their deuterated standards (BCM5-d10 and BCM7-
d10). 
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LC-HRMS chromatogram shows that BCM5 was below LOD in UHT milk (Figure 
not shown). However, BCM5 was clearly identified in the milk to which had been 
spiked with a standard of BCM5 (Fig. 16). Immediately after fermentation to pH 4.5, 
BCM5 was below LOD in spiked milk samples incubated with only S. thermophilus, 
only L. delbrueckii spp. bulgraricus or the mixture of two these bacteria (Table 15). 
Similarly, BCM5 was below LOD in yoghurt stored for one and seven days (Table 
15). However, LC-HRMS chromatogram shows that BCM5 was detected in milk 
spiked with a standard of BCM5 when milk was acidified with 1M HCl (Figs. 17, 18 
and 19). Calculation of BCM5 concentration indicated that the portion of BCM5 was 
lost upon acidification of milk to pH to 4.5 and in stored acidified milk (Table 15).   
 
Figure 17. LC-HRMS chromatogram of BCM5 and BCM7 in UHT milk spiked 
BCM5 and BCM7 standard and their deuterated standards (BCM5-d10 and BCM7-
d10) acidified to pH 4.5, zero days of storage 
6.3.2 Degradation of beta-casomorphin 7 by L. delbrueckii spp. bulgraricus and S. 
thermophilus 
It has been previously reported in this thesis (Chapter 5) that BCM7 was found in 
reconstituted milk at a low level (1.4 ng/g) and its level was partially reduced when 
milk was fermented to pH 4.8 and completely disappeared during fermentation to pH 
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4.5. Because the concentration of BCM7 in the milk was low (see Chapter 4 & 5), in 
the present study, BCM7 was added to UHT milk to study the ability of various 
bacteria to reduce the levels of this peptide during yoghurt processing.  
 
 
Figure 18. LC-HRMS chromatogram of BCM5 and BCM7 in UHT milk spiked 
BCM5 and BCM7 standard and their deuterated standards (BCM5-d10 and BCM7-
d10) acidified to pH 4.5, 1 day of storage 
LC-HRMS analysis shows that BCM7 was below LOD in the UHT milk (Figure not 
shown). BCM7 found in UHT milk spiked with standard BCM7 (Fig. 16) before 
yoghurt manufacture was considered as remaining 100 percent. UHT milk spiked 
with BCM7 fermented with either S. thermophilus or L. delbrueckii spp. bulgraricus 
or the mixture of these bacteria indicated that BCM7 was completely degraded when 
fermentation pH reached to 4.5 (Table 15). This peptide was below LOD in these 
yoghurts stored at 4 °C for one and seven days (Figure not shown). However, there 
was only a very slight change in the concentration of BCM7 when milk was acidified 
with 1 M HCl to pH 4.5 and in acidified milk was stored (Table 15). This finding 
suggests that BCM7 is stable at acidic pH, but may be susceptible to hydrolysis in 
the presence of the bacteria.     
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Figure 19. LC-HRMS chromatogram of BCM5 and BCM7 in UHT milk spiked 
BCM5 and BCM7 standard and their deuterated standards (BCM5-d10 and BCM7-
d10) acidified to pH 4.5, seven days of storage 
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Table 15. Degradation of BCM5 and BCM7 by S. thermophilus and L. delbrueckii spp. bulgraricus during fermentation and storage of 
yoghurt 
Bacteria End pH Fermentation time 
(hour) 
Storage 
(day) 
The loss of BCM5 
(%) 
The loss of BCM7  
(%) 
No bacteria 
pH 4.5 
(HCl acidification) 
- 0 28.5 0 
1 23 0 
7 25 2.1 
S.  thermophilus 4.5 
9.75 0 100 100 
1 100 100 
7 100 100 
L. delbrueckii spp. bulgraricus 4.5 
10.75 0 100 100 
1 100 100 
7 100 100 
S.  thermophilus  
+ L. delbrueckii spp. bulgraricus 
4.5 
6.5 0 100 100 
1 100 100 
7 100 100 
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6.4 Discussion 
Fermentation of milk with L. delbrueckii spp. bulgraricus and  S. thermophilus not 
only reduces the pH of milk to the required value for yoghurt, but also leads to 
changes in the peptide components in the final products. Both bacteria used 
individually or in combination for fermentation, can produce lactic acid to lower pH 
to 4.3-4.5 that is a characteristic of the final yoghurt (Paul & Somkuti, 2009). L. 
delbrueckii spp. bulgraricus and S. thermophilus can also release 
proteases/peptidases, which can hydrolyse proteins/peptides to various extents (Paul 
& Somkuti, 2009).  
Previous studies revealed that concentration of BCM5 in milk is lower than LOD and 
that of BCM7 is from 0.13 and 2.38 ng/g (see Chapters 4 and 5), these initial low 
levels make it difficult to investigate the even lower levels remaining at the final pH 
of fermentation (pH 4.5) and in the final yoghurt (yoghurt stored at 4-6 °C for at least 
one day). In the present study, the UHT milk spiked with standards of BCM5 and 
BCM7 and then fermented with mixture of L. delbrueckii spp. bulgraricus and S. 
thermophilus revealed that BCM5 and BCM7 were undetectable when pH of milk 
dropped to 4.5. This result is the same as that reported in Chapter 5. The same 
findings were observed in the milk inoculated with only S. thermophilus or only L. 
delbrueckii spp. bulgraricus and then fermented to pH 4.5 (Table 15). These results 
indicate that the reduction in levels of BCM5 and BCM7 by S. thermophilus is 
similar to that by L. delbrueckii spp. bulgraricus.   
Change in the levels of BCMs strongly depends on enzymes released from L. 
delbrueckii spp. bulgraricus and S. thermophilus. It has been well documented that 
PepX is released from LAB and hydrolyses proline-containing peptide bonds 
(Gobbetti et al., 2002). In vitro studies show that S. thermophilus produces 
intracellular and extracellular PepX (Hafeez et al., 2013; Meyer & Jordi, 1987).  L. 
delbrueckii spp. bulgraricus also has been reported to produce intracellular and 
extracellular PepX (Atlan et al., 1990; Miyakawa et al., 1991). Previous work in this 
research project has revealed that PepX released from mixture of L. delbrueckii spp. 
bulgraricus and S. thermophilus can degrade BCM7 during fermentation of milk.   
BCM5 and BCM7 are two proline-rich peptides that have a similar structure (Fig. 1). 
Hafeez et al. (2013) demonstrated that BCM7 is hydrolysed to di-, tri- and tetra-
peptides by PepX activity. Furthermore, Hafeez et al. (2013) also revealed that 
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proline residue in second position of BCM7 sequence prevented the hydrolysis of 
this peptide by the activity of another aminopetidase. As a result, BCM5 is more 
likely a substrate for PepX activity, rather than aminopetidase activity. In the present 
study, incubation with S. thermophilus alone or L. delbrueckii spp. bulgraricus alone 
gave complete degradation of BCM5 with fermentation to pH 4.5. These findings 
suggest the degradation of BCM5 is likely to be a result of PepX activity.  
In order to investigate the effect of pH alone without the presence of bacterial culture 
on the levels of BCM5 and BCM7, the milk spiked with BCMs was gradually 
acidified with 1 M HCl to pH 4.5. LC-HRMS data showed that BCM7 is more stable 
than BCM5 to this acidification (Table 15).  A previously reported in vitro study 
revealed that PepX is stable at pH 4.5 (Miyakawa et al., 1991). Furthermore, as 
reported in this thesis (Chapter 5), PepX activity was also found in yoghurt at pH 4.5. 
These findings suggest that the degradation of BCM7 during fermentation is due to 
PepX activity, while the degradation of BCM5 may involve both PepX activity and 
effect of low pH independent of bacterial activity.        
6.5 Conclusion 
This study demonstrated that L. delbrueckii spp. bulgraricus and S. thermophilus 
used for production of yoghurt are capable of reducing the level of BCM5 and 
BCM7 during fermentation of milk to produce yoghurt. These peptides are 
completely degraded by both bacteria when milk fermented to pH 4.5. However, the 
degradation of BCM7 appears due to the activity of the bacteria, while that of BCM5 
appears due to both bacterial activity and an independent effect of acidification. The 
results also show that BCM5 and BCM7 are not detectable in the yoghurt made from 
milk fermented with S. thermophilus, or L. delbrueckii spp. bulgraricus, or a mixture 
of these two bacteria.     
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CHAPTER 7 QUANTIFICATION OF BETA-CASOMORPHIN 7 CONTENT IN 
YOGHURT USING SANDWICH ELISA  
7.1 Introduction 
In recent years, ELISA has been used for quantification of BCM5 and BCM7 in 
dairy products (milk, cheese and yoghurt) and urine in several studies (Cieślińska et 
al., 2012; Jarmolowska, 2012; Sienkiewicz-Szłapka et al., 2009; Sokolov et al., 
2014).  ELISA is a simple to perform analytical technique capable of assaying a large 
number of samples simultaneously in a short time. However, the effectiveness of this 
method depends on the quality of the antibodies used against the target antigen such 
as BCM7 (Lutter et al., 2011). Furthermore, in yoghurt making, heat treatment of 
milk may modify the conformation of BCM7, leading to reduction in the binding 
affinity of the modified BCM7 to the ELISA antibodies. This may lead to 
underestimation of the BCM7 level in most commercial milks as they are usually 
treated at high temperature (Cieślińska et al., 2012). 
Yoghurt is a complex food matrix containing numerous proteins and peptides that 
can interfere with the detection of target analytes such as BCM7 (EFSA, 2009; 
Kunda et al., 2012). Several commercial ELISA kits are available for quantification 
of BCM7 in plasma, serum, cell culture fluid or other biological fluids, but not for 
quantification of this peptide in milk and yoghurt. Currently, there is no reported 
study using commercial ELISA kits for the analysis of BCM7 in milk or yoghurt.  
In previous chapters, the successful development and application of LC-MS/MS and 
LC-HRMS using stable isotope-labelled BCM7 as an internal standard for 
identification and quantification of BCM7 in yoghurt and milk have been reported. 
These methods can accurately identify and quantify this BCM at very low levels 
(sub-ng/g). Several studies have also applied LC-MS/MS methods for quantification 
of BCM7 in yoghurt and milk (De Noni, 2008; De Noni & Cattaneo, 2010; Juan-
García et al., 2009; Thiri et al., 2012). 
In the present study, a commercial sandwich ELISA kit was used for determination 
of BCM7 content in yoghurt to investigate the variation in BCM7 levels during 
fermentation of milk and in yoghurt after various periods of storage. LC-MS/MS was 
used as the “gold standard” method to compare and validate ELISA results. This 
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study will evaluate the applicability of the commercial sandwich ELISA kit for 
quantification of BCM7 in milk and yoghurt as an alternative method.  
7.2 Materials and Methods 
7.2.1 Materials and chemicals 
The chemicals used have been previously described in Section 3.2.1. The BCM7 
sandwich ELISA kit was purchased from Novateinbio (Cambridge, MA, USA). 
7.2.2 Preparation of yoghurt  
Yoghurt was prepared as described in Section 5.2.2.  
7.2.3 ELISA analysis 
7.2.3.1 Preparation of extracts 
Frozen reconstituted milk and yoghurt samples were thawed at room temperature for 
approximately 30 min and then thoroughly mixed by vortex. Ten grams (±0.0001) of 
reconstituted milk were gradually acidified with 1 M HCl to pH 4.6 and then allowed 
to stand for 10 min at room temperature. Ten grams of yoghurt sample and acidified 
reconstituted milk were centrifuged at 15,000 × g at 4 °C for 30 min. The 
supernatant was separated by decantation into glass tubes. The pH of the yoghurt 
supernatant was gradually adjusted to pH 4.6 with 1 M HCl (or 1 M NaOH) and then 
the sample was allowed to stand at room temperature for 5 min. All extracts were re-
centrifuged at 14,000 × g for 20 min at 4 οC followed by filtration through a 0.45 µm 
membrane filter. The extraction of each sample was performed in duplicate (n=2). 
7.2.3.2 Determination of beta-casomorphin 7 content  
BCM7 was quantified using the sandwich ELISA kit according to the manufacturer’s 
instructions. A brief description of the procedure is as follows: 50µL of BCM7 
standard solutions (0, 3.12, 6.25, 12.5, 50 and 100 pg/mL) and sample extract was 
placed into each well of a 96 well microplate in duplicate. After adding 100 µL of 
conjugate to each well, and mixing thoroughly by gentle swirling of the microplate, 
the microplate was covered and incubated at 37 °C for one hour. The incubation 
mixture was then removed from the well by aspiration. The wells were washed five 
times with diluted wash solution. After washing, the plate was inverted onto 
absorbent paper and left until dry. Fifty microliters of chromogen solution A and 50 
µL of chromogen solution B were added into each well and then the covered plate 
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was incubated at 37 °C for 15 min. The colour reaction was stopped by adding 50 µL 
of stop solution to each well. Optical density was measured at 450 nm using a 
microplate reader (BioTek Instruments, Winooski, USA). The concentration of 
BCM7 defined as ng/g of yoghurt in the samples was determined by comparing the 
absorbance of the samples with that of the standard curve.       
7.2.4 Liquid chromatography-tandem mass spectrometry analysis 
7.2.4.1 Purification of extracts  
Water soluble peptides from the milk and yoghurt were extracted and cleaned-up by 
SPE as described in Section 5.2.2.2. 
7.2.4.2 Determination of beta-casomorphin 7 content 
BCM7 content in the extracts of reconstituted milk and yoghurt was determined 
using LC-MS/MS as previously described in Section 5.2.2.3.   
7.3 Results  
7.3.1 Levels of beta-casomorphin 7 in reconstituted milk during fermentation  
The level of BCM7 was quantified in unfermented reconstituted milk by both ELISA 
and LC-MS/MS representing the raw material for yoghurt production. As presented 
in Chapter 5, LC-MS/MS quantified BCM7 in reconstituted milk before fermentation 
and after fermentation to pH 4.8 (Figs. 11 and 12). As indicated in Table 16, the level 
of BCM7 as determined by LC-MS/MS decreased by approximately 80% when the 
milk was fermented to pH 4.8 and further decreased to <LOD after a more prolonged 
incubation to pH 4.5. The level of BCM7 in the milk and the yoghurt fermented to 
pH 4.8 and 4.5 are given in Table 16. Its’ level in the milk as determined by ELISA 
was over two orders of magnitude lower than that obtained using LC-MS/MS. In 
contrast with the results from LC-MS/MS, BCM7 was observed to increase during 
fermentation (Table 16).  
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Table 16. BCM7 levels of milk and yoghurt fermented to different pHs as 
determined by ELISA and LC-MS/MS 
Samples 
Levels of BCM7 found by the two 
methods (ng/g a) 
LC-MS/MS b ELISA 
Reconstituted milk (pH 6.5) 1.4 ± 0.00 3.37×10-3 ± 0.0004 
Reconstituted milk fermented to pH 4.8 0.29 ± 0.01   3.52×10-3 ± 0.003 
Reconstituted milk fermented to pH 4.5 <LOD 12.22×10-3 ± 0.0009 
a Mean values ± standard deviation (SD), n = 2. 
b Data previously reported in Chapter 5 
7.3.2 Levels of beta-casomorphin 7 in yoghurt during cold storage 
The levels of BCM7 as analysed by ELISA showed an increase in level in yoghurt at 
pH 4.8 during cold storage (Table 17). However, its’ level decreased in yoghurt at 
pH 4.5 after seven days of storage. As previously reported in Chapter 5, LC-MS/MS 
analysis showed that BCM7 was detected in yoghurt at pH 4.8 after one day of 
storage (Fig. 13), but its level was <LOD after seven days of storage (Table 17). For 
yoghurt at pH 4.5, the level of BCM7 was <LOD after storage for both one and 
seven days.  
Table 17. BCM7 levels in yoghurt at different storage days as determined by ELISA 
and LC-MS/MS 
Final fermentation pH  
Storage time 
(days) 
Levels of BCM7 
 (ng/g c) 
LC-MS/MS d ELISA 
4.8 
1 0.17 ± 0.01 3.99×10-3 ± 0.0002 
7 <LOD 12.78×10-3± 0.0003 
4.5 
1 <LOD 12.19×10-3 ± 0.0009 
7 <LOD 2.19×10-3 ± 0.00003 
c Mean values ± standard deviation (SD), n = 2 
d Data previously reported  Chapter 5 
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7.4 Discussion 
LC-MS/MS used in this project was used as the “gold standard” method for 
identification and quantification of BCM7 in milk and yoghurt. On the basis of the 
results in Chapter 5, in the present study, milk or yoghurt containing BCM7 were 
considered as positive samples. In contrast, milk or yoghurt that did not contain 
BCM7 were known as negative samples. Sandwich ELISA data shows that BCM7 is 
not only present in all positive samples, but also in all negative samples. However, 
BCM7 levels in positive samples analysed by ELISA are much lower than that 
analysed by LC-MS/MS (Tables 16 and 17).  
In the case of the reconstituted milk, casein, whey protein and peptides that are 
present in the milk can remain in the extract after filtering through the 0.45 µm 
membrane used prior to sample analysis. Therefore, these compounds may interfere 
with BCM7 binding to ELISA antibodies. Furthermore, BCM10, which is released 
by cathepsin B activity, may be found in milk (Considine et al., 2004). Currently, the 
content of BCM10 in milk has not been reported. However, its’ structure is known 
and is similar to that of BCM7 (see Table 1). In present the study, the ELISA assay 
used is the sandwich ELISA, which requires BCM7 to contain at least two sites to 
bind antibodies, one of which binds to the capture antibody and another site that 
binds to the detection antibody. It can be seen that BCM10 also contained the same 
potential antibody sites as BCM7 and may have affinity with the antibodies to 
BCM7. Therefore, the result obtained may include the content of BCM10 in addition 
to that of BCM7.  
ELISA data in this study showed that there is an increase in BCM7 content during 
fermentation and storage, with exception of yoghurt sample at pH 4.5 stored for 
seven days (Tables 16 and 19), whereas content of this peptide decreased during 
these processes using LC-MS/MS (see Chapter 5) and LC-HRMS (see Chapter 6). 
According to the instructions of the manufacturer, the sandwich ELISA test has good 
sensitivity, but the present work shows that the selectivity may be problematic owing 
to potential formation and degradation of peptides, which are structurally closely 
related to BCM7, during fermentation and storage of yoghurt. Interestingly, several 
peptides known as pro-BCMs have been reported  in yoghurt such as β-CNf57-68, β-
CNf57-72, β-CNf58-72, β-CNf59-68, β-CNf59-70, β-CNf59-72, β-CNf60-72 
(BCM13) and β-CNf60-68 (BCM9) (Kunda et al., 2012; Plaisancié et al., 2013; 
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Sabeena Farvin et al., 2010; Schieber & Brückner, 2000). It can be assumed that 
these peptides contain the same antibody binding sites as those of BCM7. Therefore, 
an increase in BCM7 content measured during fermentation and storage in the 
present work may be due to formation of pro-BCMs rather than BCM7. 
The formation/degradation of peptides in yoghurt depends on time of storage. Some 
peptides may be hydrolysed and new ones may be produced during prolonged 
storage (Gobbetti et al., 2000). BCM7 as measured by LC-MS/MS is completely 
hydrolysed in yoghurt produced by fermentation of milk to pH 4.5 and stored for 
seven days (see Chapters 5 and 6). This may indicate that the decrease in BCM7 
measured by ELISA in this yoghurt sample is due to degradation of pro-BCMs rather 
than BCM7 during storage from one to seven days (Table 17).  
7.5 Conclusion 
Application of commercial sandwich ELISA allows simple and rapid quantification 
of a target analyte in a large number of samples, however, this test is very unlikely to 
be used for quantification of BCM7 in a complex matrix such as yoghurt and milk 
because of its selectivity. More research is needed to determine what precautions are 
needed to enable ELISA analysis of complex matrices. It would be recommended 
that a validation process be undertaken using spiking of samples. 
In contrast, LC-MS/MS has not only high sensitivity and selectivity for detection and 
quantification of BCM7, but also can provide simultaneous detection and 
quantification of other BCMs in milk and yoghurt. With the use of stable isotope-
labelled internal standards, LC-MS/MS can be confidently used for detection of 
BCM7 and other BCMs in milk and yoghurt as well as other dairy products such as 
cheese, infant formulas and high milk protein powder. 
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CHAPTER 8 OVERALL CONCLUSIONS AND FUTURE RESEARCH 
8.1 Overall conclusions 
LC-MS/MS and LC-HRMS are sensitive, selective and robust analytical techniques 
that can be applied for the simultaneous identification and quantification of BCM5 
and BCM7 in milk and yoghurt. Furthermore, using isotope labelled homologues as 
internal standards in these analytical techniques produced the highest confidence in 
the determination of BCM5 and BCM7 concentrations. In addition, preparation of 
samples before LC-MS/MS and LC-HRMS analysis carried out by centrifuging at 
high speed (14,000-15,000 × g) and then cleaning-up supernatants by SPE instead of 
filtering supernatants through 0.45 µm membranes can improve LOD methods.    
Commercial sandwich ELISA may be a sensitive test used for rapid quantification of 
BCM7 in a large number of samples of serum, plasma or cell culture fluid. However, 
this method is very unlikely to be used for quantitative determination of BCM7 in 
complex food matrix such as yoghurt and milk.  
The difference in BCM7 content in various products of Australian pasteurised milk 
or reconstituted milk seems to not depend on heat treatment of milk. However, it 
may be affected by β-CN A1 and β-CN A2 variant concentrations in milk collected 
from cow herds varying in their composition of A2/A2, A1/A1 or A1/A2 genotypes.   
Yoghurt processes strongly influence the stability of BCM5 and BCM7. 
Fermentation of milk with yoghurt cultures, a mixture of L. delbrueckii ssp. 
bulgaricus and S. thermophilus or L. delbrueckii ssp. bulgaricus alone or S. 
thermophilus alone, causes the degradation of BCM5 and BCM7 during incubation 
at 43 °C and complete hydrolysis of these BCMs when milk is fermented until pH 
4.5. BCMs in yoghurt produced by fermentation of milk with yoghurt cultures to pH 
4.8 decreases during cold storage and completely degraded after seven days of 
storage. Yoghurt produced by fermentation of milk to pH 4.5, which is a 
characteristic of final yoghurt, does not contain BCM5 and BCM7 with regardless 
various periods of storage.  
The degradation of BCM5 and BCM7 in yoghurt processing is likely a result of 
PepX activity, which is produced by L. delbrueckii ssp. bulgaricus and S. 
thermophilus. However, the degradation of BCM7 is owing to presence of yoghurt 
cultures, while the stability of BCM5 is affected by yoghurt cultures and pH. 
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8.2 Future research 
In this thesis, the use of liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and liquid chromatography-high resolution mass spectrometry (LC-HRMS) 
has been reported to provide an extremely sensitive, selective and robust analytical 
method that was utilised for simultaneous identification and quantification of BCM5 
and BCM7 in milk and yoghurt. In addition, the use of isotope labelled homologues 
of the BCMs as internal standards within these analytical techniques improved 
accuracy and precision of the determination of BCM5 and BCM7. Therefore, in 
future work it is proposed that LC-MS/MS and LC-HRMS method using isotope 
labelled standards will be used for the identification and quantification of BCM5, 
BCM7 and other related BCMs during simulated (in vitro) human gastrointestinal 
digestion and absorption of caseins and their peptides fragments.   
Epidemiological studies showed that the intake of cow milk containing β-CN A1 
variant from which BCM7 may be generated, has been linked to type 1 diabetes and 
ischemic heart disease. Therefore, it has been indicated that BCM7 may be a risk 
factor for development of these human diseases. Results of this thesis showed that 
BCM7 was found in various Australian milks. However, a major challenge is the 
lack of knowledge of (1) degradation and/or formation of BCM7 and other related 
BCMs in the human gastrointestinal tract as intake of cow milk already containing 
BCM7 and intake of cow milk containing pure beta casein A1 and A2 variant and (2) 
the bioavailability of intact BCM7 peptides and other related BCMs across the 
intestinal wall. Therefore, it is proposed that future research should use an in vitro 
gastrointestinal model to investigate the degradation and formation of BCM7 and 
other related BCMs after each simulated gastrointestinal stage of enzymatic digestion 
(stomach, duodenum and jejunum). The potential bioavailability of the intact BCM7 
and other related BCM peptides through intestinal absorption will then be assessed 
using the in vitro Caco-2 cell monolayer model. Throughout this proposed study, the 
formation of BCM7 and other related BCM peptides will be identified and quantified 
by the LC-MS/MS and LC-HRMS methods developed in this thesis.      
Structural difference between β-CN A1 variant and β-CN A2 variant results in 
difference in milk functionality between milk homozygous for β-CN A1 variant and 
β-CN A2 variant. Therefore, it is proposed that future work should investigate effect 
of milk containing homozygous β-CN A1 variant and β-CN A2 variant on physical 
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properties of yoghurt. In addition, it should use an in vitro gastrointestinal model to 
investigate the degradation of β-CN variants and formation of BCM7 and other 
related BCMs after digestion of these yoghurts with simulated gastrointestinal 
enzymes.   
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APPENDICES 
Appendix 1: The 2nd International Dairy Federal Symposium on Microstructure of 
Dairy Products and 5th International Dairy Federal Symposium on Science and 
Technology of Fermented Milk on 3-7 March 2014 in Melbourne, Australia  
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